measure,location,sex,age,cause,metric,year,val,upper,lower
Prevalence,United States,Male,1 to 4,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,15 to 19,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,20 to 24,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,20 to 24,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,25 to 29,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,25 to 29,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,30 to 34,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,30 to 34,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,35 to 39,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,35 to 39,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,40 to 44,Alzheimer's disease and other dementias,Percent,2017,0.00010489246257,0.000138847886929,7.57404435494e-05
Prevalence,United States,Female,40 to 44,Alzheimer's disease and other dementias,Percent,2017,0.00012592822432,0.00016260033659,9.34405892239e-05
Prevalence,United States,Male,45 to 49,Alzheimer's disease and other dementias,Percent,2017,0.000554373587917,0.000705390932234,0.00042711995518
Prevalence,United States,Female,45 to 49,Alzheimer's disease and other dementias,Percent,2017,0.000651227090881,0.000817116361521,0.000512061519736
Prevalence,United States,Male,50 to 54,Alzheimer's disease and other dementias,Percent,2017,0.000967695447597,0.00117731246774,0.000786684923943
Prevalence,United States,Female,50 to 54,Alzheimer's disease and other dementias,Percent,2017,0.0010126064277,0.00122296941655,0.000838682938234
Prevalence,United States,Male,55 to 59,Alzheimer's disease and other dementias,Percent,2017,0.00172123621028,0.00200258919708,0.00144776925316
Prevalence,United States,Female,55 to 59,Alzheimer's disease and other dementias,Percent,2017,0.00160114569137,0.00187780881705,0.00136340380767
Prevalence,United States,Male,60 to 64,Alzheimer's disease and other dementias,Percent,2017,0.00373230857582,0.00443595091536,0.0031449664943
Prevalence,United States,Female,60 to 64,Alzheimer's disease and other dementias,Percent,2017,0.00336050190938,0.00397712239373,0.00283708020715
Prevalence,United States,Male,65 to 69,Alzheimer's disease and other dementias,Percent,2017,0.00841849186363,0.00980652833251,0.00713809448079
Prevalence,United States,Female,65 to 69,Alzheimer's disease and other dementias,Percent,2017,0.00797781151274,0.00934345223896,0.00673545780786
Prevalence,United States,Male,70 to 74,Alzheimer's disease and other dementias,Percent,2017,0.0209786501562,0.0244989673219,0.0179231091908
Prevalence,United States,Female,70 to 74,Alzheimer's disease and other dementias,Percent,2017,0.021369876694,0.024918145641,0.0180233823889
Prevalence,United States,Male,75 to 79,Alzheimer's disease and other dementias,Percent,2017,0.0481021679312,0.0568813371329,0.0405293088744
Prevalence,United States,Female,75 to 79,Alzheimer's disease and other dementias,Percent,2017,0.0523784991134,0.0615685243286,0.0440469822799
Prevalence,United States,Male,<1 year,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Alzheimer's disease and other dementias,Percent,2017,0.0929984710819,0.110350758621,0.0786816136429
Prevalence,United States,Female,80 to 84,Alzheimer's disease and other dementias,Percent,2017,0.106536673424,0.126375422209,0.0900216369146
Prevalence,United States,Male,85 to 89,Alzheimer's disease and other dementias,Percent,2017,0.153653320836,0.181764951098,0.130780602551
Prevalence,United States,Female,85 to 89,Alzheimer's disease and other dementias,Percent,2017,0.183272739756,0.217460145129,0.155907471652
Prevalence,United States,Male,90 to 94,Alzheimer's disease and other dementias,Percent,2017,0.216174709404,0.25362014158,0.182133639471
Prevalence,United States,Female,90 to 94,Alzheimer's disease and other dementias,Percent,2017,0.273642268532,0.31990553574,0.229667617694
Prevalence,United States,Male,95 plus,Alzheimer's disease and other dementias,Percent,2017,0.262359484854,0.320379785907,0.210332470191
Prevalence,United States,Female,95 plus,Alzheimer's disease and other dementias,Percent,2017,0.362938834224,0.442503094629,0.292568382487
Prevalence,United States,Male,1 to 4,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,15 to 19,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,20 to 24,Parkinson's disease,Percent,2017,1.26951705698e-06,2.06521359645e-06,6.0629271525e-07
Prevalence,United States,Female,20 to 24,Parkinson's disease,Percent,2017,7.71836254117e-07,1.4012917265e-06,1.97121782212e-07
Prevalence,United States,Male,25 to 29,Parkinson's disease,Percent,2017,8.49369529687e-06,1.38297725275e-05,4.0399382304e-06
Prevalence,United States,Female,25 to 29,Parkinson's disease,Percent,2017,5.24764827343e-06,9.52918494925e-06,1.35006009289e-06
Prevalence,United States,Male,30 to 34,Parkinson's disease,Percent,2017,2.30400562916e-05,3.48338691554e-05,1.32931407864e-05
Prevalence,United States,Female,30 to 34,Parkinson's disease,Percent,2017,1.44966252218e-05,2.38323569079e-05,6.00567583911e-06
Prevalence,United States,Male,35 to 39,Parkinson's disease,Percent,2017,4.63625446716e-05,6.17111588371e-05,3.2796193361e-05
Prevalence,United States,Female,35 to 39,Parkinson's disease,Percent,2017,2.9941013072e-05,4.15319242031e-05,2.02492715659e-05
Prevalence,United States,Male,40 to 44,Parkinson's disease,Percent,2017,9.89003191845e-05,0.000127885667928,7.46687797832e-05
Prevalence,United States,Female,40 to 44,Parkinson's disease,Percent,2017,6.06146687579e-05,8.21454448246e-05,4.45525480218e-05
Prevalence,United States,Male,45 to 49,Parkinson's disease,Percent,2017,0.000255697116814,0.000314842206065,0.000197647168006
Prevalence,United States,Female,45 to 49,Parkinson's disease,Percent,2017,0.000139096643499,0.000173402877046,0.000107493886275
Prevalence,United States,Male,50 to 54,Parkinson's disease,Percent,2017,0.000584102707726,0.000711545654749,0.000465457602988
Prevalence,United States,Female,50 to 54,Parkinson's disease,Percent,2017,0.000300733179787,0.000375664430431,0.000231418565079
Prevalence,United States,Male,55 to 59,Parkinson's disease,Percent,2017,0.00130706266194,0.0015819394321,0.00107054881999
Prevalence,United States,Female,55 to 59,Parkinson's disease,Percent,2017,0.000667026586008,0.000817034569982,0.000539004339873
Prevalence,United States,Male,60 to 64,Parkinson's disease,Percent,2017,0.002682358919,0.0032614114126,0.00218500393892
Prevalence,United States,Female,60 to 64,Parkinson's disease,Percent,2017,0.00138752079209,0.00169913682735,0.00112231744027
Prevalence,United States,Male,65 to 69,Parkinson's disease,Percent,2017,0.00544560295669,0.00647987552728,0.00447905552139
Prevalence,United States,Female,65 to 69,Parkinson's disease,Percent,2017,0.00290211158172,0.00345407182921,0.00237694656203
Prevalence,United States,Male,70 to 74,Parkinson's disease,Percent,2017,0.00987334493343,0.0120546807472,0.00798750542203
Prevalence,United States,Female,70 to 74,Parkinson's disease,Percent,2017,0.00535564457591,0.00660100291096,0.00433486666737
Prevalence,United States,Male,75 to 79,Parkinson's disease,Percent,2017,0.0164718557728,0.0192649186053,0.0136481500463
Prevalence,United States,Female,75 to 79,Parkinson's disease,Percent,2017,0.00896637508183,0.0104509686244,0.00748355271612
Prevalence,United States,Male,<1 year,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Parkinson's disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Parkinson's disease,Percent,2017,0.0231474260827,0.0282324903592,0.0183690229742
Prevalence,United States,Female,80 to 84,Parkinson's disease,Percent,2017,0.0126826159224,0.0152245498981,0.0101388846226
Prevalence,United States,Male,85 to 89,Parkinson's disease,Percent,2017,0.025431976384,0.0300896221868,0.0208660421825
Prevalence,United States,Female,85 to 89,Parkinson's disease,Percent,2017,0.0139457779194,0.016394903789,0.0114272418031
Prevalence,United States,Male,90 to 94,Parkinson's disease,Percent,2017,0.0233231892525,0.0284393719281,0.0187396822784
Prevalence,United States,Female,90 to 94,Parkinson's disease,Percent,2017,0.0127523631903,0.015455342256,0.0104308205704
Prevalence,United States,Male,95 plus,Parkinson's disease,Percent,2017,0.0180983769801,0.0234010362097,0.013315945099
Prevalence,United States,Female,95 plus,Parkinson's disease,Percent,2017,0.0101421278824,0.0129601020189,0.00758908696859
Prevalence,United States,Male,1 to 4,Epilepsy,Percent,2017,0.00493380992828,0.00688006286926,0.00329563970368
Prevalence,United States,Female,1 to 4,Epilepsy,Percent,2017,0.00401442287787,0.00558902962784,0.00268505981839
Prevalence,United States,Male,5 to 9,Epilepsy,Percent,2017,0.005904224217,0.00825087110364,0.00392777429118
Prevalence,United States,Female,5 to 9,Epilepsy,Percent,2017,0.00505225720621,0.00707730952752,0.0033966563173
Prevalence,United States,Male,10 to 14,Epilepsy,Percent,2017,0.00562811644945,0.00770519694704,0.00380791542971
Prevalence,United States,Female,10 to 14,Epilepsy,Percent,2017,0.00511608993556,0.0069939145393,0.00345232805242
Prevalence,United States,Male,15 to 19,Epilepsy,Percent,2017,0.00499344767349,0.00672718308613,0.00337304419771
Prevalence,United States,Female,15 to 19,Epilepsy,Percent,2017,0.0047854154586,0.00641250757051,0.00326736158167
Prevalence,United States,Male,20 to 24,Epilepsy,Percent,2017,0.00448369496967,0.00604262822203,0.00300778623068
Prevalence,United States,Female,20 to 24,Epilepsy,Percent,2017,0.00458900865586,0.00617349704242,0.00307638144511
Prevalence,United States,Male,25 to 29,Epilepsy,Percent,2017,0.00373406925705,0.00507860699098,0.00249604813304
Prevalence,United States,Female,25 to 29,Epilepsy,Percent,2017,0.00423798233973,0.00571949369371,0.00286906290403
Prevalence,United States,Male,30 to 34,Epilepsy,Percent,2017,0.00307175893745,0.0042219420804,0.00208571960496
Prevalence,United States,Female,30 to 34,Epilepsy,Percent,2017,0.00386334379618,0.00526052241886,0.00266441635845
Prevalence,United States,Male,35 to 39,Epilepsy,Percent,2017,0.00281476818681,0.0038077166013,0.00192912063954
Prevalence,United States,Female,35 to 39,Epilepsy,Percent,2017,0.00371365818717,0.00502113895228,0.00257969492894
Prevalence,United States,Male,40 to 44,Epilepsy,Percent,2017,0.00280792021351,0.00386893286898,0.00188916173682
Prevalence,United States,Female,40 to 44,Epilepsy,Percent,2017,0.0037364206095,0.00516606715688,0.00251998397328
Prevalence,United States,Male,45 to 49,Epilepsy,Percent,2017,0.00300777977883,0.00408945660442,0.00203490540682
Prevalence,United States,Female,45 to 49,Epilepsy,Percent,2017,0.00383833962916,0.00523846313436,0.00256649499082
Prevalence,United States,Male,50 to 54,Epilepsy,Percent,2017,0.00335874566488,0.00452402447553,0.0022474373688
Prevalence,United States,Female,50 to 54,Epilepsy,Percent,2017,0.0039977476916,0.00534497331553,0.00270286785063
Prevalence,United States,Male,55 to 59,Epilepsy,Percent,2017,0.0038485637772,0.00516745346792,0.00263097727088
Prevalence,United States,Female,55 to 59,Epilepsy,Percent,2017,0.00428232213564,0.00576104719027,0.00294716351443
Prevalence,United States,Male,60 to 64,Epilepsy,Percent,2017,0.004574486637,0.00623275477346,0.00308761323918
Prevalence,United States,Female,60 to 64,Epilepsy,Percent,2017,0.00481813899617,0.00653427451703,0.00331014033709
Prevalence,United States,Male,65 to 69,Epilepsy,Percent,2017,0.00562451918662,0.00762825908466,0.00377664400656
Prevalence,United States,Female,65 to 69,Epilepsy,Percent,2017,0.00565961451234,0.00767844755568,0.0037812861917
Prevalence,United States,Male,70 to 74,Epilepsy,Percent,2017,0.00691522178789,0.00929468829897,0.00463999139474
Prevalence,United States,Female,70 to 74,Epilepsy,Percent,2017,0.00667431451302,0.00895979571273,0.00449523126774
Prevalence,United States,Male,75 to 79,Epilepsy,Percent,2017,0.00824422236677,0.0109583431468,0.00557119317903
Prevalence,United States,Female,75 to 79,Epilepsy,Percent,2017,0.00775001420529,0.0102783442329,0.00527268955409
Prevalence,United States,Male,<1 year,Epilepsy,Percent,2017,0.00495642124765,0.00727514485832,0.00304431112744
Prevalence,United States,Female,<1 year,Epilepsy,Percent,2017,0.00412547621495,0.00602240873778,0.00259175862314
Prevalence,United States,Male,80 to 84,Epilepsy,Percent,2017,0.00943765343839,0.0125696096259,0.00639203223666
Prevalence,United States,Female,80 to 84,Epilepsy,Percent,2017,0.00868123898858,0.0115232923068,0.00591263901495
Prevalence,United States,Male,85 to 89,Epilepsy,Percent,2017,0.0100492468778,0.0134358728675,0.00681327771321
Prevalence,United States,Female,85 to 89,Epilepsy,Percent,2017,0.0088976315954,0.0119108996521,0.0060390575944
Prevalence,United States,Male,90 to 94,Epilepsy,Percent,2017,0.0100779014768,0.0136403478002,0.00679380271767
Prevalence,United States,Female,90 to 94,Epilepsy,Percent,2017,0.00844606400509,0.0114208839953,0.00566015671911
Prevalence,United States,Male,95 plus,Epilepsy,Percent,2017,0.00983916117596,0.0133268549926,0.00655144325947
Prevalence,United States,Female,95 plus,Epilepsy,Percent,2017,0.00774118864603,0.0104503652389,0.00516758822379
Prevalence,United States,Male,1 to 4,Multiple sclerosis,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Multiple sclerosis,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Multiple sclerosis,Percent,2017,3.22321470854e-06,4.60250929894e-06,1.88089682531e-06
Prevalence,United States,Female,5 to 9,Multiple sclerosis,Percent,2017,4.06458399153e-06,5.84548790752e-06,2.34782288538e-06
Prevalence,United States,Male,10 to 14,Multiple sclerosis,Percent,2017,2.30229772142e-05,2.96773140274e-05,1.63570325472e-05
Prevalence,United States,Female,10 to 14,Multiple sclerosis,Percent,2017,3.40585284107e-05,4.57063192871e-05,2.4868500009e-05
Prevalence,United States,Male,15 to 19,Multiple sclerosis,Percent,2017,8.14515625561e-05,0.000102862970003,6.60994940799e-05
Prevalence,United States,Female,15 to 19,Multiple sclerosis,Percent,2017,0.000168997654131,0.000208336271918,0.000134843562225
Prevalence,United States,Male,20 to 24,Multiple sclerosis,Percent,2017,0.000239598373614,0.000279659776062,0.000202243655188
Prevalence,United States,Female,20 to 24,Multiple sclerosis,Percent,2017,0.000614508751272,0.000725136257066,0.000512745159057
Prevalence,United States,Male,25 to 29,Multiple sclerosis,Percent,2017,0.000508083518045,0.000601512588945,0.00042741568696
Prevalence,United States,Female,25 to 29,Multiple sclerosis,Percent,2017,0.00138576043069,0.00159010936588,0.00116669164858
Prevalence,United States,Male,30 to 34,Multiple sclerosis,Percent,2017,0.0008046214529,0.000902423624926,0.000701842905235
Prevalence,United States,Female,30 to 34,Multiple sclerosis,Percent,2017,0.00223644424395,0.00245116903916,0.00199669009562
Prevalence,United States,Male,35 to 39,Multiple sclerosis,Percent,2017,0.00105787179746,0.00116232766836,0.000951543296519
Prevalence,United States,Female,35 to 39,Multiple sclerosis,Percent,2017,0.00274567839334,0.00294153601827,0.00255076117538
Prevalence,United States,Male,40 to 44,Multiple sclerosis,Percent,2017,0.00121752448524,0.0013169909097,0.00112289199784
Prevalence,United States,Female,40 to 44,Multiple sclerosis,Percent,2017,0.00285778854229,0.00305224479379,0.00266999005742
Prevalence,United States,Male,45 to 49,Multiple sclerosis,Percent,2017,0.00130976525759,0.00140824126873,0.00121260711055
Prevalence,United States,Female,45 to 49,Multiple sclerosis,Percent,2017,0.00286706444453,0.00306220409627,0.00268038493632
Prevalence,United States,Male,50 to 54,Multiple sclerosis,Percent,2017,0.0013365896719,0.00142994610795,0.00124942100803
Prevalence,United States,Female,50 to 54,Multiple sclerosis,Percent,2017,0.00282530917168,0.00301664330005,0.00264521727731
Prevalence,United States,Male,55 to 59,Multiple sclerosis,Percent,2017,0.00130247326094,0.00139155699329,0.00122044545632
Prevalence,United States,Female,55 to 59,Multiple sclerosis,Percent,2017,0.00273964045864,0.00292678424043,0.00256895214121
Prevalence,United States,Male,60 to 64,Multiple sclerosis,Percent,2017,0.0012137492721,0.00129411511498,0.00113792830538
Prevalence,United States,Female,60 to 64,Multiple sclerosis,Percent,2017,0.0026030043183,0.00278699246193,0.00243931286534
Prevalence,United States,Male,65 to 69,Multiple sclerosis,Percent,2017,0.00108727911565,0.00115847764063,0.0010190758014
Prevalence,United States,Female,65 to 69,Multiple sclerosis,Percent,2017,0.00241571988279,0.00258131298773,0.00226092411417
Prevalence,United States,Male,70 to 74,Multiple sclerosis,Percent,2017,0.000942021097241,0.00100640036974,0.000881945082277
Prevalence,United States,Female,70 to 74,Multiple sclerosis,Percent,2017,0.00218489203099,0.00233784595452,0.00204000248846
Prevalence,United States,Male,75 to 79,Multiple sclerosis,Percent,2017,0.000795506027581,0.000852336967802,0.000741704182681
Prevalence,United States,Female,75 to 79,Multiple sclerosis,Percent,2017,0.00190692595496,0.00204408503724,0.00177473607065
Prevalence,United States,Male,<1 year,Multiple sclerosis,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Multiple sclerosis,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Multiple sclerosis,Percent,2017,0.000656457733004,0.000704412410241,0.000608856665452
Prevalence,United States,Female,80 to 84,Multiple sclerosis,Percent,2017,0.00160500650475,0.00172487135901,0.00148623437277
Prevalence,United States,Male,85 to 89,Multiple sclerosis,Percent,2017,0.000530567188752,0.000572927794702,0.000484672994514
Prevalence,United States,Female,85 to 89,Multiple sclerosis,Percent,2017,0.00130721544587,0.0014160475836,0.00119715970081
Prevalence,United States,Male,90 to 94,Multiple sclerosis,Percent,2017,0.000416294967699,0.000458430241077,0.000375046263915
Prevalence,United States,Female,90 to 94,Multiple sclerosis,Percent,2017,0.00102756388773,0.00112973843236,0.000918617653552
Prevalence,United States,Male,95 plus,Multiple sclerosis,Percent,2017,0.000318299205425,0.000358053257486,0.000277035644981
Prevalence,United States,Female,95 plus,Multiple sclerosis,Percent,2017,0.000784591098109,0.000882289518562,0.000673342945799
Prevalence,United States,Male,1 to 4,Motor neuron disease,Percent,2017,8.24738318221e-05,9.61464620773e-05,7.02622894961e-05
Prevalence,United States,Female,1 to 4,Motor neuron disease,Percent,2017,6.73578319418e-05,7.76485596568e-05,5.78031764223e-05
Prevalence,United States,Male,5 to 9,Motor neuron disease,Percent,2017,7.76534235192e-05,9.07943178229e-05,6.71105326172e-05
Prevalence,United States,Female,5 to 9,Motor neuron disease,Percent,2017,6.34058946021e-05,7.30362588026e-05,5.46622382501e-05
Prevalence,United States,Male,10 to 14,Motor neuron disease,Percent,2017,7.07169850112e-05,8.15502320841e-05,6.08488306811e-05
Prevalence,United States,Female,10 to 14,Motor neuron disease,Percent,2017,5.57076508926e-05,6.45007884382e-05,4.82558807452e-05
Prevalence,United States,Male,15 to 19,Motor neuron disease,Percent,2017,6.38934980174e-05,7.41001183176e-05,5.51860794167e-05
Prevalence,United States,Female,15 to 19,Motor neuron disease,Percent,2017,4.96060594563e-05,5.72283157571e-05,4.31613994478e-05
Prevalence,United States,Male,20 to 24,Motor neuron disease,Percent,2017,5.97704749638e-05,6.88732337195e-05,5.16770308608e-05
Prevalence,United States,Female,20 to 24,Motor neuron disease,Percent,2017,4.73824051163e-05,5.43720876729e-05,4.12885596431e-05
Prevalence,United States,Male,25 to 29,Motor neuron disease,Percent,2017,5.52685537513e-05,6.37670775785e-05,4.84088295315e-05
Prevalence,United States,Female,25 to 29,Motor neuron disease,Percent,2017,4.46870522383e-05,5.13201628954e-05,3.91439807359e-05
Prevalence,United States,Male,30 to 34,Motor neuron disease,Percent,2017,5.11002297385e-05,5.8678501642e-05,4.4495217672e-05
Prevalence,United States,Female,30 to 34,Motor neuron disease,Percent,2017,4.15654459809e-05,4.75899535431e-05,3.64311175511e-05
Prevalence,United States,Male,35 to 39,Motor neuron disease,Percent,2017,5.5264346762e-05,6.59652919471e-05,4.63692355322e-05
Prevalence,United States,Female,35 to 39,Motor neuron disease,Percent,2017,4.21508338805e-05,4.82407030747e-05,3.64168968066e-05
Prevalence,United States,Male,40 to 44,Motor neuron disease,Percent,2017,8.04344838826e-05,9.98533022844e-05,6.33103475313e-05
Prevalence,United States,Female,40 to 44,Motor neuron disease,Percent,2017,5.28565409679e-05,6.34988166833e-05,4.3707353275e-05
Prevalence,United States,Male,45 to 49,Motor neuron disease,Percent,2017,0.000115626453907,0.000143615435508,9.12833839967e-05
Prevalence,United States,Female,45 to 49,Motor neuron disease,Percent,2017,6.99824422102e-05,8.60525194821e-05,5.5787462302e-05
Prevalence,United States,Male,50 to 54,Motor neuron disease,Percent,2017,0.000146708463538,0.000183261558854,0.000117114481207
Prevalence,United States,Female,50 to 54,Motor neuron disease,Percent,2017,9.46142629993e-05,0.00011855294085,7.48379495879e-05
Prevalence,United States,Male,55 to 59,Motor neuron disease,Percent,2017,0.000181069761508,0.000221388895174,0.00014603954988
Prevalence,United States,Female,55 to 59,Motor neuron disease,Percent,2017,0.000124182694814,0.000154971616476,9.71984832028e-05
Prevalence,United States,Male,60 to 64,Motor neuron disease,Percent,2017,0.000252494501013,0.000307122934763,0.000205860087648
Prevalence,United States,Female,60 to 64,Motor neuron disease,Percent,2017,0.000164900835317,0.000203882800487,0.000132978565031
Prevalence,United States,Male,65 to 69,Motor neuron disease,Percent,2017,0.000345660333355,0.000413809314801,0.00028512903892
Prevalence,United States,Female,65 to 69,Motor neuron disease,Percent,2017,0.000232220909516,0.000282240660128,0.00018737813735
Prevalence,United States,Male,70 to 74,Motor neuron disease,Percent,2017,0.000433873142173,0.000518310404568,0.000362692241314
Prevalence,United States,Female,70 to 74,Motor neuron disease,Percent,2017,0.000303509229554,0.000365073002857,0.000251726379423
Prevalence,United States,Male,75 to 79,Motor neuron disease,Percent,2017,0.000474822652973,0.000572883988911,0.0003943249492
Prevalence,United States,Female,75 to 79,Motor neuron disease,Percent,2017,0.000325609328096,0.000395350836141,0.000266756200703
Prevalence,United States,Male,<1 year,Motor neuron disease,Percent,2017,7.10723245334e-05,8.51533214702e-05,5.64745779729e-05
Prevalence,United States,Female,<1 year,Motor neuron disease,Percent,2017,5.63513960987e-05,6.43486900585e-05,4.84939270051e-05
Prevalence,United States,Male,80 to 84,Motor neuron disease,Percent,2017,0.00042599058201,0.000515889593572,0.000342328721143
Prevalence,United States,Female,80 to 84,Motor neuron disease,Percent,2017,0.000278584450525,0.000336402858379,0.000223144015831
Prevalence,United States,Male,85 to 89,Motor neuron disease,Percent,2017,0.000359360278312,0.000435684940162,0.000298551328747
Prevalence,United States,Female,85 to 89,Motor neuron disease,Percent,2017,0.000237026816311,0.000289807402893,0.000193712480038
Prevalence,United States,Male,90 to 94,Motor neuron disease,Percent,2017,0.00028599280874,0.000344205429338,0.000236691163779
Prevalence,United States,Female,90 to 94,Motor neuron disease,Percent,2017,0.000177620394139,0.000219346528146,0.000143072073627
Prevalence,United States,Male,95 plus,Motor neuron disease,Percent,2017,0.000261028356274,0.000327462279585,0.000199770339709
Prevalence,United States,Female,95 plus,Motor neuron disease,Percent,2017,0.000157950879034,0.000199994414574,0.000117443164093
Prevalence,United States,Male,1 to 4,Esophageal cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Esophageal cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Esophageal cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Esophageal cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Esophageal cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Esophageal cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Esophageal cancer,Percent,2017,5.3808901622e-07,6.06609634688e-07,4.79401100966e-07
Prevalence,United States,Female,15 to 19,Esophageal cancer,Percent,2017,7.11626209317e-07,8.21763453163e-07,6.15486400702e-07
Prevalence,United States,Male,20 to 24,Esophageal cancer,Percent,2017,1.9679959936e-06,2.20712889132e-06,1.78022088562e-06
Prevalence,United States,Female,20 to 24,Esophageal cancer,Percent,2017,1.01191322287e-06,1.14691421231e-06,8.84284819403e-07
Prevalence,United States,Male,25 to 29,Esophageal cancer,Percent,2017,5.63760870356e-06,6.35412157664e-06,5.06245277836e-06
Prevalence,United States,Female,25 to 29,Esophageal cancer,Percent,2017,3.68816088156e-06,4.13371995751e-06,3.22945458022e-06
Prevalence,United States,Male,30 to 34,Esophageal cancer,Percent,2017,1.11523836517e-05,1.23779033167e-05,1.01144534155e-05
Prevalence,United States,Female,30 to 34,Esophageal cancer,Percent,2017,5.81417578814e-06,6.63718285736e-06,5.04624430745e-06
Prevalence,United States,Male,35 to 39,Esophageal cancer,Percent,2017,2.43749276304e-05,2.68819200397e-05,2.20231873935e-05
Prevalence,United States,Female,35 to 39,Esophageal cancer,Percent,2017,1.12430641295e-05,1.29657346785e-05,9.59013435994e-06
Prevalence,United States,Male,40 to 44,Esophageal cancer,Percent,2017,5.3558114064e-05,5.78157926643e-05,4.93358461526e-05
Prevalence,United States,Female,40 to 44,Esophageal cancer,Percent,2017,2.30888513e-05,2.66032356663e-05,2.01980295584e-05
Prevalence,United States,Male,45 to 49,Esophageal cancer,Percent,2017,0.000117426062478,0.000125600565346,0.000109672565482
Prevalence,United States,Female,45 to 49,Esophageal cancer,Percent,2017,4.05030364522e-05,4.44828197869e-05,3.67702560836e-05
Prevalence,United States,Male,50 to 54,Esophageal cancer,Percent,2017,0.000203748480685,0.000215259111923,0.000192844347539
Prevalence,United States,Female,50 to 54,Esophageal cancer,Percent,2017,5.3786161902e-05,5.81190827435e-05,4.97294297047e-05
Prevalence,United States,Male,55 to 59,Esophageal cancer,Percent,2017,0.000365145906288,0.000386708947224,0.00034448135371
Prevalence,United States,Female,55 to 59,Esophageal cancer,Percent,2017,8.08126536452e-05,8.69980460893e-05,7.52968807268e-05
Prevalence,United States,Male,60 to 64,Esophageal cancer,Percent,2017,0.000514918729019,0.000546367924292,0.000487391849337
Prevalence,United States,Female,60 to 64,Esophageal cancer,Percent,2017,0.000120533254602,0.000129847823744,0.000111460128319
Prevalence,United States,Male,65 to 69,Esophageal cancer,Percent,2017,0.000633447571875,0.000673372036177,0.000597228241436
Prevalence,United States,Female,65 to 69,Esophageal cancer,Percent,2017,0.00014540307647,0.000157620462546,0.000135405108007
Prevalence,United States,Male,70 to 74,Esophageal cancer,Percent,2017,0.000676890465021,0.00071758363765,0.000636991655323
Prevalence,United States,Female,70 to 74,Esophageal cancer,Percent,2017,0.000175101124031,0.000189499698872,0.000163323106855
Prevalence,United States,Male,75 to 79,Esophageal cancer,Percent,2017,0.000663325560586,0.000706639938561,0.000621678940548
Prevalence,United States,Female,75 to 79,Esophageal cancer,Percent,2017,0.00018372529373,0.000198903054697,0.000170340227027
Prevalence,United States,Male,<1 year,Esophageal cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Esophageal cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Esophageal cancer,Percent,2017,0.000481502267513,0.000516912164884,0.000451034787369
Prevalence,United States,Female,80 to 84,Esophageal cancer,Percent,2017,0.000162069497028,0.000175536733401,0.000150491705078
Prevalence,United States,Male,85 to 89,Esophageal cancer,Percent,2017,0.000508341095907,0.000543621865193,0.000477011202104
Prevalence,United States,Female,85 to 89,Esophageal cancer,Percent,2017,0.00018946627348,0.000204238321656,0.000176348535922
Prevalence,United States,Male,90 to 94,Esophageal cancer,Percent,2017,0.000470710127711,0.000504437433549,0.000440164418288
Prevalence,United States,Female,90 to 94,Esophageal cancer,Percent,2017,0.00019463096209,0.000209521334909,0.000179600524849
Prevalence,United States,Male,95 plus,Esophageal cancer,Percent,2017,0.000292346382554,0.000316232423732,0.000271406794961
Prevalence,United States,Female,95 plus,Esophageal cancer,Percent,2017,0.000114117098088,0.000123603981368,0.000106058504325
Prevalence,United States,Male,1 to 4,Stomach cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Stomach cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Stomach cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Stomach cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Stomach cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Stomach cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Stomach cancer,Percent,2017,1.89552540735e-06,2.21467339219e-06,1.64330066015e-06
Prevalence,United States,Female,15 to 19,Stomach cancer,Percent,2017,1.32270544409e-06,1.49839477585e-06,1.16635349757e-06
Prevalence,United States,Male,20 to 24,Stomach cancer,Percent,2017,1.11456558172e-05,1.27724907612e-05,9.74106242631e-06
Prevalence,United States,Female,20 to 24,Stomach cancer,Percent,2017,7.52644004287e-06,8.50438820347e-06,6.64153202602e-06
Prevalence,United States,Male,25 to 29,Stomach cancer,Percent,2017,3.17376131726e-05,3.60049855379e-05,2.84481045739e-05
Prevalence,United States,Female,25 to 29,Stomach cancer,Percent,2017,2.3322709766e-05,2.61387906142e-05,2.07312611836e-05
Prevalence,United States,Male,30 to 34,Stomach cancer,Percent,2017,7.04675314589e-05,7.9535514453e-05,6.35901028754e-05
Prevalence,United States,Female,30 to 34,Stomach cancer,Percent,2017,5.36910703214e-05,6.02472828247e-05,4.79399199595e-05
Prevalence,United States,Male,35 to 39,Stomach cancer,Percent,2017,0.000107890031398,0.000122089943849,9.63257632793e-05
Prevalence,United States,Female,35 to 39,Stomach cancer,Percent,2017,6.15941493918e-05,6.96925258556e-05,5.41740541716e-05
Prevalence,United States,Male,40 to 44,Stomach cancer,Percent,2017,0.000139195484051,0.000156366424155,0.000122674313463
Prevalence,United States,Female,40 to 44,Stomach cancer,Percent,2017,6.6339758182e-05,7.43741334923e-05,5.95895418626e-05
Prevalence,United States,Male,45 to 49,Stomach cancer,Percent,2017,0.000203771721254,0.000224487091115,0.000184042302533
Prevalence,United States,Female,45 to 49,Stomach cancer,Percent,2017,9.85333076118e-05,0.000108701956789,8.87179562645e-05
Prevalence,United States,Male,50 to 54,Stomach cancer,Percent,2017,0.000370517849481,0.000404078815847,0.000337854668042
Prevalence,United States,Female,50 to 54,Stomach cancer,Percent,2017,0.00016680693855,0.000185799016203,0.000150202240875
Prevalence,United States,Male,55 to 59,Stomach cancer,Percent,2017,0.000566579114363,0.000621491477799,0.000519851494998
Prevalence,United States,Female,55 to 59,Stomach cancer,Percent,2017,0.000251045011946,0.000276388460544,0.000229873903445
Prevalence,United States,Male,60 to 64,Stomach cancer,Percent,2017,0.000809622538057,0.000878236073368,0.000746018921022
Prevalence,United States,Female,60 to 64,Stomach cancer,Percent,2017,0.000314899215821,0.00034138538665,0.000289213190721
Prevalence,United States,Male,65 to 69,Stomach cancer,Percent,2017,0.00105889839643,0.00114417522037,0.000981372527514
Prevalence,United States,Female,65 to 69,Stomach cancer,Percent,2017,0.000474063625249,0.000514829143154,0.000436774790328
Prevalence,United States,Male,70 to 74,Stomach cancer,Percent,2017,0.00145422687323,0.00155582148471,0.00135225121563
Prevalence,United States,Female,70 to 74,Stomach cancer,Percent,2017,0.000715118267279,0.000769054543564,0.000665850249108
Prevalence,United States,Male,75 to 79,Stomach cancer,Percent,2017,0.00174516157557,0.00188843058228,0.00162711619722
Prevalence,United States,Female,75 to 79,Stomach cancer,Percent,2017,0.000896314863407,0.000964093490186,0.00082945278714
Prevalence,United States,Male,<1 year,Stomach cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Stomach cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Stomach cancer,Percent,2017,0.00165507421743,0.00176969469622,0.0015401875073
Prevalence,United States,Female,80 to 84,Stomach cancer,Percent,2017,0.000911991888254,0.000973673733341,0.000849048718595
Prevalence,United States,Male,85 to 89,Stomach cancer,Percent,2017,0.00207644058732,0.00220515213128,0.00193406418116
Prevalence,United States,Female,85 to 89,Stomach cancer,Percent,2017,0.00120650086361,0.00128974995285,0.00112419349869
Prevalence,United States,Male,90 to 94,Stomach cancer,Percent,2017,0.00210663007477,0.00224707412781,0.00197674042881
Prevalence,United States,Female,90 to 94,Stomach cancer,Percent,2017,0.00133321538353,0.00142251899705,0.00124904480792
Prevalence,United States,Male,95 plus,Stomach cancer,Percent,2017,0.000921959985167,0.000992396639346,0.000855171075378
Prevalence,United States,Female,95 plus,Stomach cancer,Percent,2017,0.000658771400141,0.00070617900518,0.000611384936495
Prevalence,United States,Male,1 to 4,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,15 to 19,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,20 to 24,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,20 to 24,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,25 to 29,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,25 to 29,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,30 to 34,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,30 to 34,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,35 to 39,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,35 to 39,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,40 to 44,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,40 to 44,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,45 to 49,Liver cancer,Percent,2017,1.05524779213e-05,2.61888171183e-05,0.0
Prevalence,United States,Female,45 to 49,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,50 to 54,Liver cancer,Percent,2017,0.000220206151749,0.000279756830658,0.000162353829839
Prevalence,United States,Female,50 to 54,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,55 to 59,Liver cancer,Percent,2017,0.000534034887869,0.000636118007671,0.000438546219958
Prevalence,United States,Female,55 to 59,Liver cancer,Percent,2017,2.61481539358e-05,4.95912715817e-05,8.02957280525e-06
Prevalence,United States,Male,60 to 64,Liver cancer,Percent,2017,0.000588073106455,0.000691248763286,0.000495598576207
Prevalence,United States,Female,60 to 64,Liver cancer,Percent,2017,2.74357023252e-05,5.24510186542e-05,8.52560528516e-06
Prevalence,United States,Male,65 to 69,Liver cancer,Percent,2017,0.0004946373646,0.000586131550453,0.000406157280492
Prevalence,United States,Female,65 to 69,Liver cancer,Percent,2017,2.8669905199e-05,5.34709833023e-05,1.08954015784e-05
Prevalence,United States,Male,70 to 74,Liver cancer,Percent,2017,0.000433728532833,0.000518874938597,0.000359328631231
Prevalence,United States,Female,70 to 74,Liver cancer,Percent,2017,3.76622689583e-05,6.95538239317e-05,1.37918159965e-05
Prevalence,United States,Male,75 to 79,Liver cancer,Percent,2017,0.000251314792016,0.000309797532138,0.000197759579877
Prevalence,United States,Female,75 to 79,Liver cancer,Percent,2017,1.61212113934e-05,3.83354276823e-05,9.17699746525e-07
Prevalence,United States,Male,<1 year,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Liver cancer,Percent,2017,0.000269131272581,0.000327762572583,0.000210498575879
Prevalence,United States,Female,80 to 84,Liver cancer,Percent,2017,1.06488436999e-06,2.42724787892e-06,2.42717795476e-07
Prevalence,United States,Male,85 to 89,Liver cancer,Percent,2017,0.00025035879359,0.000309065193064,0.000193858740813
Prevalence,United States,Female,85 to 89,Liver cancer,Percent,2017,1.6223859804e-06,3.42756146755e-06,2.85636737959e-07
Prevalence,United States,Male,90 to 94,Liver cancer,Percent,2017,0.000206124559973,0.000262264598037,0.000153670608395
Prevalence,United States,Female,90 to 94,Liver cancer,Percent,2017,1.84215781996e-06,3.8844027444e-06,3.23698119483e-07
Prevalence,United States,Male,95 plus,Liver cancer,Percent,2017,7.39157804934e-06,1.31422704075e-05,2.94392237298e-06
Prevalence,United States,Female,95 plus,Liver cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,1 to 4,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Hypertensive heart disease,Percent,2017,5.64171358096e-07,9.76797767764e-07,2.7016881232e-07
Prevalence,United States,Female,15 to 19,Hypertensive heart disease,Percent,2017,5.52893912378e-07,9.49104086305e-07,2.61844774688e-07
Prevalence,United States,Male,20 to 24,Hypertensive heart disease,Percent,2017,5.42708243085e-05,7.64309093807e-05,3.71822153979e-05
Prevalence,United States,Female,20 to 24,Hypertensive heart disease,Percent,2017,5.63631487295e-05,8.01744843136e-05,3.83653984487e-05
Prevalence,United States,Male,25 to 29,Hypertensive heart disease,Percent,2017,0.000189156591407,0.00026113386994,0.00013001297844
Prevalence,United States,Female,25 to 29,Hypertensive heart disease,Percent,2017,0.000232398100718,0.000318724460165,0.000157387187653
Prevalence,United States,Male,30 to 34,Hypertensive heart disease,Percent,2017,0.000401439953802,0.00051214302826,0.00029999530676
Prevalence,United States,Female,30 to 34,Hypertensive heart disease,Percent,2017,0.000478654414228,0.00061722838342,0.000357144633095
Prevalence,United States,Male,35 to 39,Hypertensive heart disease,Percent,2017,0.000675690658108,0.000866330509751,0.000500098646391
Prevalence,United States,Female,35 to 39,Hypertensive heart disease,Percent,2017,0.000685503387998,0.000884402598616,0.000511592997357
Prevalence,United States,Male,40 to 44,Hypertensive heart disease,Percent,2017,0.00103608681753,0.00131907404706,0.000784987754215
Prevalence,United States,Female,40 to 44,Hypertensive heart disease,Percent,2017,0.000963590686012,0.00123520106902,0.000730488747297
Prevalence,United States,Male,45 to 49,Hypertensive heart disease,Percent,2017,0.00199676710439,0.00248020720533,0.00155475442044
Prevalence,United States,Female,45 to 49,Hypertensive heart disease,Percent,2017,0.00178481744756,0.00220792964261,0.00141813035117
Prevalence,United States,Male,50 to 54,Hypertensive heart disease,Percent,2017,0.00312261908721,0.00393183380175,0.00237090729509
Prevalence,United States,Female,50 to 54,Hypertensive heart disease,Percent,2017,0.00268683161794,0.00330682694638,0.00208904292742
Prevalence,United States,Male,55 to 59,Hypertensive heart disease,Percent,2017,0.00419991666112,0.00534430904342,0.00319108022804
Prevalence,United States,Female,55 to 59,Hypertensive heart disease,Percent,2017,0.00332849470661,0.00415734705915,0.00257162844426
Prevalence,United States,Male,60 to 64,Hypertensive heart disease,Percent,2017,0.00562073008118,0.00755645597867,0.00392434764474
Prevalence,United States,Female,60 to 64,Hypertensive heart disease,Percent,2017,0.00449058113565,0.00586767961719,0.00324944684761
Prevalence,United States,Male,65 to 69,Hypertensive heart disease,Percent,2017,0.00707584957857,0.00916313011646,0.00525361226786
Prevalence,United States,Female,65 to 69,Hypertensive heart disease,Percent,2017,0.00663495731171,0.00851670976322,0.00497836858715
Prevalence,United States,Male,70 to 74,Hypertensive heart disease,Percent,2017,0.00814283686252,0.0110968069596,0.00557758158479
Prevalence,United States,Female,70 to 74,Hypertensive heart disease,Percent,2017,0.00900300027721,0.0118950924057,0.00643358233847
Prevalence,United States,Male,75 to 79,Hypertensive heart disease,Percent,2017,0.00958541003367,0.0127113795636,0.00692633771036
Prevalence,United States,Female,75 to 79,Hypertensive heart disease,Percent,2017,0.0124329276258,0.0164088410317,0.00902352383537
Prevalence,United States,Male,<1 year,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Hypertensive heart disease,Percent,2017,0.0121406680666,0.0167907461562,0.0082511956205
Prevalence,United States,Female,80 to 84,Hypertensive heart disease,Percent,2017,0.0188572571572,0.0253314445958,0.013242620694
Prevalence,United States,Male,85 to 89,Hypertensive heart disease,Percent,2017,0.0170243404651,0.0236336464856,0.0115769061863
Prevalence,United States,Female,85 to 89,Hypertensive heart disease,Percent,2017,0.0302293574003,0.0405551599354,0.0211999233243
Prevalence,United States,Male,90 to 94,Hypertensive heart disease,Percent,2017,0.0224923314163,0.0311156115791,0.0146537672623
Prevalence,United States,Female,90 to 94,Hypertensive heart disease,Percent,2017,0.0413653840612,0.0551600981805,0.0284369599779
Prevalence,United States,Male,95 plus,Hypertensive heart disease,Percent,2017,0.0265275077305,0.0413338247785,0.0152194254867
Prevalence,United States,Female,95 plus,Hypertensive heart disease,Percent,2017,0.0462811036375,0.0683746777193,0.0281670213068
Prevalence,United States,Male,1 to 4,Chronic respiratory diseases,Percent,2017,0.131946604805,0.162407534101,0.103807827452
Prevalence,United States,Female,1 to 4,Chronic respiratory diseases,Percent,2017,0.0765932759189,0.0964910855129,0.0588093013003
Prevalence,United States,Male,5 to 9,Chronic respiratory diseases,Percent,2017,0.128654229358,0.156435466906,0.103923238346
Prevalence,United States,Female,5 to 9,Chronic respiratory diseases,Percent,2017,0.0812346688864,0.101403552078,0.0648333607786
Prevalence,United States,Male,10 to 14,Chronic respiratory diseases,Percent,2017,0.0812738200353,0.0963483783899,0.0666778934004
Prevalence,United States,Female,10 to 14,Chronic respiratory diseases,Percent,2017,0.058287474433,0.0695102602799,0.0480247590169
Prevalence,United States,Male,15 to 19,Chronic respiratory diseases,Percent,2017,0.0421840807893,0.0506695542178,0.0346979117617
Prevalence,United States,Female,15 to 19,Chronic respiratory diseases,Percent,2017,0.0481661738531,0.0574010463092,0.0396796144545
Prevalence,United States,Male,20 to 24,Chronic respiratory diseases,Percent,2017,0.0287505562086,0.033036732035,0.0243828802131
Prevalence,United States,Female,20 to 24,Chronic respiratory diseases,Percent,2017,0.042859285444,0.0495710305475,0.0361620211834
Prevalence,United States,Male,25 to 29,Chronic respiratory diseases,Percent,2017,0.0276079828745,0.0314685264519,0.0238065837943
Prevalence,United States,Female,25 to 29,Chronic respiratory diseases,Percent,2017,0.0449803373847,0.0520296692105,0.0392247003199
Prevalence,United States,Male,30 to 34,Chronic respiratory diseases,Percent,2017,0.0317569675612,0.0357008316129,0.027959810345
Prevalence,United States,Female,30 to 34,Chronic respiratory diseases,Percent,2017,0.0524258828045,0.0597809254943,0.0459298735198
Prevalence,United States,Male,35 to 39,Chronic respiratory diseases,Percent,2017,0.0382676385402,0.0428397941881,0.0341298128824
Prevalence,United States,Female,35 to 39,Chronic respiratory diseases,Percent,2017,0.0624523087853,0.0705638896606,0.0556695722098
Prevalence,United States,Male,40 to 44,Chronic respiratory diseases,Percent,2017,0.0492401444061,0.0553333198438,0.043283283068
Prevalence,United States,Female,40 to 44,Chronic respiratory diseases,Percent,2017,0.0783669228785,0.0874884462126,0.06967496089
Prevalence,United States,Male,45 to 49,Chronic respiratory diseases,Percent,2017,0.0677711836718,0.0750811319004,0.0609945844798
Prevalence,United States,Female,45 to 49,Chronic respiratory diseases,Percent,2017,0.102183284158,0.112346429971,0.0925746340069
Prevalence,United States,Male,50 to 54,Chronic respiratory diseases,Percent,2017,0.0940938306004,0.103858973481,0.0851856360905
Prevalence,United States,Female,50 to 54,Chronic respiratory diseases,Percent,2017,0.127888513873,0.139634223706,0.116957602763
Prevalence,United States,Male,55 to 59,Chronic respiratory diseases,Percent,2017,0.126393082965,0.138916639227,0.114959199841
Prevalence,United States,Female,55 to 59,Chronic respiratory diseases,Percent,2017,0.151688436063,0.164653916042,0.139023585332
Prevalence,United States,Male,60 to 64,Chronic respiratory diseases,Percent,2017,0.168043144795,0.185200203009,0.152370072975
Prevalence,United States,Female,60 to 64,Chronic respiratory diseases,Percent,2017,0.182111620992,0.199074227902,0.166944210538
Prevalence,United States,Male,65 to 69,Chronic respiratory diseases,Percent,2017,0.226530370169,0.247880464106,0.206217352119
Prevalence,United States,Female,65 to 69,Chronic respiratory diseases,Percent,2017,0.23252318085,0.253316919713,0.213538910727
Prevalence,United States,Male,70 to 74,Chronic respiratory diseases,Percent,2017,0.289349236992,0.313218316343,0.267002103538
Prevalence,United States,Female,70 to 74,Chronic respiratory diseases,Percent,2017,0.286534816045,0.308870363338,0.266252431618
Prevalence,United States,Male,75 to 79,Chronic respiratory diseases,Percent,2017,0.333673060986,0.358618935503,0.309745785375
Prevalence,United States,Female,75 to 79,Chronic respiratory diseases,Percent,2017,0.314991940415,0.338997112713,0.292756267108
Prevalence,United States,Male,<1 year,Chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Chronic respiratory diseases,Percent,2017,0.351191584426,0.378709828084,0.325864104405
Prevalence,United States,Female,80 to 84,Chronic respiratory diseases,Percent,2017,0.31689507991,0.341226806297,0.295813750885
Prevalence,United States,Male,85 to 89,Chronic respiratory diseases,Percent,2017,0.350461287564,0.377834772031,0.324885683663
Prevalence,United States,Female,85 to 89,Chronic respiratory diseases,Percent,2017,0.30736030428,0.330921783414,0.28482366191
Prevalence,United States,Male,90 to 94,Chronic respiratory diseases,Percent,2017,0.340490420724,0.368485898555,0.314576507726
Prevalence,United States,Female,90 to 94,Chronic respiratory diseases,Percent,2017,0.293983505536,0.3191508141,0.270277394407
Prevalence,United States,Male,95 plus,Chronic respiratory diseases,Percent,2017,0.322436279907,0.353954942441,0.293466933618
Prevalence,United States,Female,95 plus,Chronic respiratory diseases,Percent,2017,0.276704204614,0.303382410197,0.251438220872
Prevalence,United States,Male,1 to 4,Respiratory infections and tuberculosis,Percent,2017,0.14771348927,0.176163649475,0.122915914208
Prevalence,United States,Female,1 to 4,Respiratory infections and tuberculosis,Percent,2017,0.131494205706,0.157915754583,0.108657835017
Prevalence,United States,Male,5 to 9,Respiratory infections and tuberculosis,Percent,2017,0.11107609979,0.135414847782,0.0888149137675
Prevalence,United States,Female,5 to 9,Respiratory infections and tuberculosis,Percent,2017,0.102320081377,0.124630563414,0.0811192061745
Prevalence,United States,Male,10 to 14,Respiratory infections and tuberculosis,Percent,2017,0.0912697044584,0.110403308266,0.0727110433445
Prevalence,United States,Female,10 to 14,Respiratory infections and tuberculosis,Percent,2017,0.0847987775209,0.102778702454,0.0670379789383
Prevalence,United States,Male,15 to 19,Respiratory infections and tuberculosis,Percent,2017,0.0934001640245,0.116200806575,0.0747852843641
Prevalence,United States,Female,15 to 19,Respiratory infections and tuberculosis,Percent,2017,0.0856606603707,0.106259021013,0.0687982645185
Prevalence,United States,Male,20 to 24,Respiratory infections and tuberculosis,Percent,2017,0.099793938945,0.125691134238,0.0781251587926
Prevalence,United States,Female,20 to 24,Respiratory infections and tuberculosis,Percent,2017,0.0887120227888,0.111688144141,0.0700800227671
Prevalence,United States,Male,25 to 29,Respiratory infections and tuberculosis,Percent,2017,0.104287340216,0.135404691922,0.0806238847468
Prevalence,United States,Female,25 to 29,Respiratory infections and tuberculosis,Percent,2017,0.0952217805843,0.120818472535,0.0740717784334
Prevalence,United States,Male,30 to 34,Respiratory infections and tuberculosis,Percent,2017,0.109706419301,0.140418337419,0.0832410439272
Prevalence,United States,Female,30 to 34,Respiratory infections and tuberculosis,Percent,2017,0.107318405635,0.134505991662,0.0834948754567
Prevalence,United States,Male,35 to 39,Respiratory infections and tuberculosis,Percent,2017,0.126678812807,0.162248643816,0.0968836987777
Prevalence,United States,Female,35 to 39,Respiratory infections and tuberculosis,Percent,2017,0.116161348666,0.146264687288,0.0902638645134
Prevalence,United States,Male,40 to 44,Respiratory infections and tuberculosis,Percent,2017,0.139453528662,0.179654210304,0.104818932604
Prevalence,United States,Female,40 to 44,Respiratory infections and tuberculosis,Percent,2017,0.11335997325,0.144596937732,0.0860205786475
Prevalence,United States,Male,45 to 49,Respiratory infections and tuberculosis,Percent,2017,0.13982248555,0.184439105068,0.104029896028
Prevalence,United States,Female,45 to 49,Respiratory infections and tuberculosis,Percent,2017,0.115214184868,0.147860163793,0.0875138713272
Prevalence,United States,Male,50 to 54,Respiratory infections and tuberculosis,Percent,2017,0.138093110251,0.179429146992,0.103260936742
Prevalence,United States,Female,50 to 54,Respiratory infections and tuberculosis,Percent,2017,0.124101328164,0.160136925016,0.0948900327237
Prevalence,United States,Male,55 to 59,Respiratory infections and tuberculosis,Percent,2017,0.142607572194,0.187576987505,0.106154131084
Prevalence,United States,Female,55 to 59,Respiratory infections and tuberculosis,Percent,2017,0.12874871209,0.167077337621,0.0975994049692
Prevalence,United States,Male,60 to 64,Respiratory infections and tuberculosis,Percent,2017,0.150018147322,0.197924723557,0.111858042157
Prevalence,United States,Female,60 to 64,Respiratory infections and tuberculosis,Percent,2017,0.127594929958,0.166564161489,0.0962974266295
Prevalence,United States,Male,65 to 69,Respiratory infections and tuberculosis,Percent,2017,0.150160359006,0.200343622725,0.10953119788
Prevalence,United States,Female,65 to 69,Respiratory infections and tuberculosis,Percent,2017,0.119202050229,0.15653743943,0.0885523468974
Prevalence,United States,Male,70 to 74,Respiratory infections and tuberculosis,Percent,2017,0.134984896592,0.176025161678,0.10301375898
Prevalence,United States,Female,70 to 74,Respiratory infections and tuberculosis,Percent,2017,0.0972340645632,0.126701877722,0.0743107490392
Prevalence,United States,Male,75 to 79,Respiratory infections and tuberculosis,Percent,2017,0.11724856296,0.147982650948,0.0912637851345
Prevalence,United States,Female,75 to 79,Respiratory infections and tuberculosis,Percent,2017,0.079921831451,0.101022536728,0.06253153683
Prevalence,United States,Male,<1 year,Respiratory infections and tuberculosis,Percent,2017,0.202572638035,0.241932922516,0.161716485938
Prevalence,United States,Female,<1 year,Respiratory infections and tuberculosis,Percent,2017,0.168661853269,0.196678653824,0.142513026792
Prevalence,United States,Male,80 to 84,Respiratory infections and tuberculosis,Percent,2017,0.10688692626,0.129931917415,0.0861901897866
Prevalence,United States,Female,80 to 84,Respiratory infections and tuberculosis,Percent,2017,0.0747543942048,0.0896332029672,0.0612411143959
Prevalence,United States,Male,85 to 89,Respiratory infections and tuberculosis,Percent,2017,0.0985517486507,0.117479919918,0.0821516652154
Prevalence,United States,Female,85 to 89,Respiratory infections and tuberculosis,Percent,2017,0.0708654228136,0.0845826307971,0.0589595641818
Prevalence,United States,Male,90 to 94,Respiratory infections and tuberculosis,Percent,2017,0.0910709488693,0.109023967924,0.0755104269731
Prevalence,United States,Female,90 to 94,Respiratory infections and tuberculosis,Percent,2017,0.068541545917,0.0820025148993,0.0567683708745
Prevalence,United States,Male,95 plus,Respiratory infections and tuberculosis,Percent,2017,0.0836814866199,0.107235086991,0.0648714068452
Prevalence,United States,Female,95 plus,Respiratory infections and tuberculosis,Percent,2017,0.0668120131782,0.0856565456548,0.0521179230603
Prevalence,United States,Male,1 to 4,Enteric infections,Percent,2017,0.0121162440337,0.0167110093307,0.00858749382761
Prevalence,United States,Female,1 to 4,Enteric infections,Percent,2017,0.0100352284138,0.0138203726077,0.00707047240292
Prevalence,United States,Male,5 to 9,Enteric infections,Percent,2017,0.00487639256134,0.00716975245609,0.00315267784507
Prevalence,United States,Female,5 to 9,Enteric infections,Percent,2017,0.00438671907128,0.00653456434733,0.00289526112895
Prevalence,United States,Male,10 to 14,Enteric infections,Percent,2017,0.00662461815471,0.0081283442834,0.0053941784912
Prevalence,United States,Female,10 to 14,Enteric infections,Percent,2017,0.00666493655595,0.00808089572811,0.00558127273997
Prevalence,United States,Male,15 to 19,Enteric infections,Percent,2017,0.00842237437812,0.00966177658666,0.00723706640634
Prevalence,United States,Female,15 to 19,Enteric infections,Percent,2017,0.00897565193979,0.0103556059945,0.00767044184372
Prevalence,United States,Male,20 to 24,Enteric infections,Percent,2017,0.00940228371102,0.0108359917985,0.00800855893915
Prevalence,United States,Female,20 to 24,Enteric infections,Percent,2017,0.0104588147653,0.011965383342,0.00892262121635
Prevalence,United States,Male,25 to 29,Enteric infections,Percent,2017,0.00878231409605,0.00986786026027,0.00767588700858
Prevalence,United States,Female,25 to 29,Enteric infections,Percent,2017,0.0100159541173,0.0112426340246,0.00868409781935
Prevalence,United States,Male,30 to 34,Enteric infections,Percent,2017,0.00827774155653,0.00921819213984,0.00730854628281
Prevalence,United States,Female,30 to 34,Enteric infections,Percent,2017,0.00961693260334,0.0105916616458,0.00852961205133
Prevalence,United States,Male,35 to 39,Enteric infections,Percent,2017,0.0078603708961,0.00861872308277,0.00704484510543
Prevalence,United States,Female,35 to 39,Enteric infections,Percent,2017,0.00929637483244,0.0101333004137,0.00843017519944
Prevalence,United States,Male,40 to 44,Enteric infections,Percent,2017,0.00745483523103,0.0081375959386,0.00678985231178
Prevalence,United States,Female,40 to 44,Enteric infections,Percent,2017,0.00897362563483,0.00976385570114,0.00819023416961
Prevalence,United States,Male,45 to 49,Enteric infections,Percent,2017,0.00705557774636,0.00769839722504,0.00641151724244
Prevalence,United States,Female,45 to 49,Enteric infections,Percent,2017,0.00867512219819,0.0095618326325,0.0078515563894
Prevalence,United States,Male,50 to 54,Enteric infections,Percent,2017,0.00666396061894,0.00741205783615,0.00594822315211
Prevalence,United States,Female,50 to 54,Enteric infections,Percent,2017,0.00838717128723,0.00934996298043,0.00748833277782
Prevalence,United States,Male,55 to 59,Enteric infections,Percent,2017,0.00629254958334,0.00714597086996,0.00538781566973
Prevalence,United States,Female,55 to 59,Enteric infections,Percent,2017,0.00809297037336,0.00920239674724,0.0069900194738
Prevalence,United States,Male,60 to 64,Enteric infections,Percent,2017,0.00636380480541,0.00720303484952,0.00548340837688
Prevalence,United States,Female,60 to 64,Enteric infections,Percent,2017,0.00841933926754,0.00947226146596,0.00740033813985
Prevalence,United States,Male,65 to 69,Enteric infections,Percent,2017,0.00703399410378,0.00771852458951,0.00630885764534
Prevalence,United States,Female,65 to 69,Enteric infections,Percent,2017,0.00956959534245,0.0104384464157,0.00861730801752
Prevalence,United States,Male,70 to 74,Enteric infections,Percent,2017,0.0077186517426,0.00853921653794,0.00690738445537
Prevalence,United States,Female,70 to 74,Enteric infections,Percent,2017,0.0107557223362,0.0118722300205,0.00965085757303
Prevalence,United States,Male,75 to 79,Enteric infections,Percent,2017,0.00843767610887,0.00956266550616,0.00735467293678
Prevalence,United States,Female,75 to 79,Enteric infections,Percent,2017,0.0119695359423,0.0133632539633,0.0105856442399
Prevalence,United States,Male,<1 year,Enteric infections,Percent,2017,0.0175740178629,0.0220706360829,0.0135258755624
Prevalence,United States,Female,<1 year,Enteric infections,Percent,2017,0.0145600189331,0.0179820099919,0.0118125235535
Prevalence,United States,Male,80 to 84,Enteric infections,Percent,2017,0.00966143534065,0.0108470653414,0.00854433713099
Prevalence,United States,Female,80 to 84,Enteric infections,Percent,2017,0.0131431027954,0.0146255227483,0.0116478932358
Prevalence,United States,Male,85 to 89,Enteric infections,Percent,2017,0.0115357023638,0.0127162819506,0.0103584668203
Prevalence,United States,Female,85 to 89,Enteric infections,Percent,2017,0.0141940710611,0.015665893242,0.0128275289197
Prevalence,United States,Male,90 to 94,Enteric infections,Percent,2017,0.013291919329,0.0151692459756,0.0117057684402
Prevalence,United States,Female,90 to 94,Enteric infections,Percent,2017,0.0152175936659,0.0172586640243,0.0134050750736
Prevalence,United States,Male,95 plus,Enteric infections,Percent,2017,0.0149000875884,0.0177128991667,0.0125757768019
Prevalence,United States,Female,95 plus,Enteric infections,Percent,2017,0.016204800507,0.0191202190411,0.0136891170739
Prevalence,United States,Male,1 to 4,Colon and rectum cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Colon and rectum cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Colon and rectum cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Colon and rectum cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Colon and rectum cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Colon and rectum cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Colon and rectum cancer,Percent,2017,2.83773519667e-05,3.23346898617e-05,2.52801052385e-05
Prevalence,United States,Female,15 to 19,Colon and rectum cancer,Percent,2017,1.69490022559e-05,1.89171049497e-05,1.55411195687e-05
Prevalence,United States,Male,20 to 24,Colon and rectum cancer,Percent,2017,0.000109076338026,0.000121200901127,9.85256211472e-05
Prevalence,United States,Female,20 to 24,Colon and rectum cancer,Percent,2017,7.04570113612e-05,7.82286224801e-05,6.22092122596e-05
Prevalence,United States,Male,25 to 29,Colon and rectum cancer,Percent,2017,0.000291591187821,0.000323319041128,0.000246685819536
Prevalence,United States,Female,25 to 29,Colon and rectum cancer,Percent,2017,0.000202571314378,0.000226071615698,0.000170527101135
Prevalence,United States,Male,30 to 34,Colon and rectum cancer,Percent,2017,0.000577156058098,0.000636943445516,0.000477691650083
Prevalence,United States,Female,30 to 34,Colon and rectum cancer,Percent,2017,0.00047258128152,0.000530404637772,0.000392323784468
Prevalence,United States,Male,35 to 39,Colon and rectum cancer,Percent,2017,0.00102970147576,0.0011307802998,0.000879684895487
Prevalence,United States,Female,35 to 39,Colon and rectum cancer,Percent,2017,0.00085583764523,0.000941597768442,0.000753179246623
Prevalence,United States,Male,40 to 44,Colon and rectum cancer,Percent,2017,0.00173589008923,0.00187872588989,0.00157980984511
Prevalence,United States,Female,40 to 44,Colon and rectum cancer,Percent,2017,0.00144469320993,0.0015519312607,0.00133819850745
Prevalence,United States,Male,45 to 49,Colon and rectum cancer,Percent,2017,0.00276982150134,0.00297324874871,0.00256757480115
Prevalence,United States,Female,45 to 49,Colon and rectum cancer,Percent,2017,0.00221308451469,0.00235576465414,0.00206149425618
Prevalence,United States,Male,50 to 54,Colon and rectum cancer,Percent,2017,0.00508992934034,0.00545897198357,0.00472671984904
Prevalence,United States,Female,50 to 54,Colon and rectum cancer,Percent,2017,0.00378449546311,0.00403235201637,0.00353801778615
Prevalence,United States,Male,55 to 59,Colon and rectum cancer,Percent,2017,0.00739444423118,0.0078827819098,0.00687664875638
Prevalence,United States,Female,55 to 59,Colon and rectum cancer,Percent,2017,0.0050442725755,0.00533399789442,0.00474340152131
Prevalence,United States,Male,60 to 64,Colon and rectum cancer,Percent,2017,0.010144341391,0.0107861844618,0.00944492776772
Prevalence,United States,Female,60 to 64,Colon and rectum cancer,Percent,2017,0.00646303143537,0.00682763525662,0.00610853091342
Prevalence,United States,Male,65 to 69,Colon and rectum cancer,Percent,2017,0.0131290895685,0.0138510547512,0.0124251264342
Prevalence,United States,Female,65 to 69,Colon and rectum cancer,Percent,2017,0.00869344047998,0.00919916860594,0.00819952246642
Prevalence,United States,Male,70 to 74,Colon and rectum cancer,Percent,2017,0.0162275242538,0.0171680863134,0.0153571897901
Prevalence,United States,Female,70 to 74,Colon and rectum cancer,Percent,2017,0.0113337227864,0.0119625031995,0.0107675449492
Prevalence,United States,Male,75 to 79,Colon and rectum cancer,Percent,2017,0.0189598267168,0.0199905687088,0.0179359225382
Prevalence,United States,Female,75 to 79,Colon and rectum cancer,Percent,2017,0.013958762958,0.01471217363,0.0132289211593
Prevalence,United States,Male,<1 year,Colon and rectum cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Colon and rectum cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Colon and rectum cancer,Percent,2017,0.0151754670547,0.0160097417406,0.0143603054769
Prevalence,United States,Female,80 to 84,Colon and rectum cancer,Percent,2017,0.0121061398308,0.0127316025954,0.0115214673872
Prevalence,United States,Male,85 to 89,Colon and rectum cancer,Percent,2017,0.0191737898102,0.0202760599119,0.0181367593524
Prevalence,United States,Female,85 to 89,Colon and rectum cancer,Percent,2017,0.0159934368518,0.0168874209647,0.0152357742832
Prevalence,United States,Male,90 to 94,Colon and rectum cancer,Percent,2017,0.0211680194134,0.0223896670178,0.0199941331141
Prevalence,United States,Female,90 to 94,Colon and rectum cancer,Percent,2017,0.0185073565861,0.0194367368601,0.0176520248082
Prevalence,United States,Male,95 plus,Colon and rectum cancer,Percent,2017,0.0111990143932,0.0116982255699,0.0106773184203
Prevalence,United States,Female,95 plus,Colon and rectum cancer,Percent,2017,0.00894845726366,0.00931799993001,0.00861169714152
Prevalence,United States,Male,1 to 4,Lip and oral cavity cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Lip and oral cavity cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Lip and oral cavity cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Lip and oral cavity cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Lip and oral cavity cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Lip and oral cavity cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Lip and oral cavity cancer,Percent,2017,1.13766661242e-05,1.28597290484e-05,1.02070787912e-05
Prevalence,United States,Female,15 to 19,Lip and oral cavity cancer,Percent,2017,1.031441343e-05,1.15254939192e-05,9.28387909828e-06
Prevalence,United States,Male,20 to 24,Lip and oral cavity cancer,Percent,2017,3.69964886995e-05,4.18888065119e-05,3.29108075262e-05
Prevalence,United States,Female,20 to 24,Lip and oral cavity cancer,Percent,2017,2.22955933025e-05,2.54070664149e-05,1.92363567726e-05
Prevalence,United States,Male,25 to 29,Lip and oral cavity cancer,Percent,2017,9.58177102502e-05,0.000109623264028,8.22088187835e-05
Prevalence,United States,Female,25 to 29,Lip and oral cavity cancer,Percent,2017,5.36690999089e-05,6.2364122515e-05,4.47412419234e-05
Prevalence,United States,Male,30 to 34,Lip and oral cavity cancer,Percent,2017,0.000135843076353,0.000151011452023,0.000116110321228
Prevalence,United States,Female,30 to 34,Lip and oral cavity cancer,Percent,2017,7.4507233514e-05,8.54589054332e-05,6.32689737239e-05
Prevalence,United States,Male,35 to 39,Lip and oral cavity cancer,Percent,2017,0.000223805593284,0.000245275399095,0.00019500665927
Prevalence,United States,Female,35 to 39,Lip and oral cavity cancer,Percent,2017,0.000108772433687,0.000122394049569,9.50886772225e-05
Prevalence,United States,Male,40 to 44,Lip and oral cavity cancer,Percent,2017,0.000298591117853,0.00033240957168,0.00026708841913
Prevalence,United States,Female,40 to 44,Lip and oral cavity cancer,Percent,2017,0.000140220284056,0.000156206749375,0.000126071056259
Prevalence,United States,Male,45 to 49,Lip and oral cavity cancer,Percent,2017,0.000530008166367,0.000586716422075,0.00047798799504
Prevalence,United States,Female,45 to 49,Lip and oral cavity cancer,Percent,2017,0.000213787944,0.000234512270847,0.000194185971021
Prevalence,United States,Male,50 to 54,Lip and oral cavity cancer,Percent,2017,0.00102112029659,0.00111996362753,0.00092922276034
Prevalence,United States,Female,50 to 54,Lip and oral cavity cancer,Percent,2017,0.000374734421829,0.000411409620786,0.000340044077177
Prevalence,United States,Male,55 to 59,Lip and oral cavity cancer,Percent,2017,0.00158704950624,0.00173240679642,0.00144731494134
Prevalence,United States,Female,55 to 59,Lip and oral cavity cancer,Percent,2017,0.000509651064897,0.000556193277571,0.000460213097851
Prevalence,United States,Male,60 to 64,Lip and oral cavity cancer,Percent,2017,0.00196202257306,0.00214554822858,0.00178754808367
Prevalence,United States,Female,60 to 64,Lip and oral cavity cancer,Percent,2017,0.000583159108917,0.000635127483514,0.0005298963058
Prevalence,United States,Male,65 to 69,Lip and oral cavity cancer,Percent,2017,0.0022595657574,0.00247178056145,0.00207531855699
Prevalence,United States,Female,65 to 69,Lip and oral cavity cancer,Percent,2017,0.000779797223478,0.000851762299487,0.000716699989826
Prevalence,United States,Male,70 to 74,Lip and oral cavity cancer,Percent,2017,0.00225125080577,0.00246017043213,0.00205396477474
Prevalence,United States,Female,70 to 74,Lip and oral cavity cancer,Percent,2017,0.000937623826433,0.00102129974396,0.000857715885284
Prevalence,United States,Male,75 to 79,Lip and oral cavity cancer,Percent,2017,0.00245634537687,0.00269308446442,0.00223132898274
Prevalence,United States,Female,75 to 79,Lip and oral cavity cancer,Percent,2017,0.00108834052435,0.00119677896781,0.000987634686523
Prevalence,United States,Male,<1 year,Lip and oral cavity cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Lip and oral cavity cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Lip and oral cavity cancer,Percent,2017,0.00199971503126,0.0021823329701,0.00182390303817
Prevalence,United States,Female,80 to 84,Lip and oral cavity cancer,Percent,2017,0.00091460633435,0.000994677924811,0.000842053018353
Prevalence,United States,Male,85 to 89,Lip and oral cavity cancer,Percent,2017,0.00219549153744,0.00240610055393,0.00200819261785
Prevalence,United States,Female,85 to 89,Lip and oral cavity cancer,Percent,2017,0.00112818400199,0.00121900591851,0.00103641476096
Prevalence,United States,Male,90 to 94,Lip and oral cavity cancer,Percent,2017,0.00232004680269,0.0025404127915,0.00211402823351
Prevalence,United States,Female,90 to 94,Lip and oral cavity cancer,Percent,2017,0.00136668416935,0.00148289716009,0.00125322023633
Prevalence,United States,Male,95 plus,Lip and oral cavity cancer,Percent,2017,0.000756068773421,0.000825840176334,0.000689236370617
Prevalence,United States,Female,95 plus,Lip and oral cavity cancer,Percent,2017,0.000456370451184,0.000495195585595,0.000419598736325
Prevalence,United States,Male,1 to 4,Nasopharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Nasopharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Nasopharynx cancer,Percent,2017,5.7218170485e-06,6.34171913609e-06,5.12954066809e-06
Prevalence,United States,Female,5 to 9,Nasopharynx cancer,Percent,2017,4.14950538238e-06,4.73030329056e-06,3.50105500016e-06
Prevalence,United States,Male,10 to 14,Nasopharynx cancer,Percent,2017,1.91479432357e-05,2.66237643123e-05,1.29965281788e-05
Prevalence,United States,Female,10 to 14,Nasopharynx cancer,Percent,2017,1.20707941226e-05,1.68546618436e-05,7.90916920713e-06
Prevalence,United States,Male,15 to 19,Nasopharynx cancer,Percent,2017,8.12501169928e-06,9.38560245021e-06,7.0533949465e-06
Prevalence,United States,Female,15 to 19,Nasopharynx cancer,Percent,2017,3.3018485169e-06,3.83214190403e-06,2.76242261922e-06
Prevalence,United States,Male,20 to 24,Nasopharynx cancer,Percent,2017,2.28169012002e-05,2.71672359462e-05,1.85789534722e-05
Prevalence,United States,Female,20 to 24,Nasopharynx cancer,Percent,2017,8.30722984114e-06,9.82892310807e-06,6.72392702067e-06
Prevalence,United States,Male,25 to 29,Nasopharynx cancer,Percent,2017,2.28141743691e-05,2.70318847121e-05,1.79327696956e-05
Prevalence,United States,Female,25 to 29,Nasopharynx cancer,Percent,2017,1.01967949344e-05,1.17704374072e-05,8.63321911425e-06
Prevalence,United States,Male,30 to 34,Nasopharynx cancer,Percent,2017,2.54929104122e-05,3.06830908795e-05,2.00348536957e-05
Prevalence,United States,Female,30 to 34,Nasopharynx cancer,Percent,2017,1.33353577428e-05,1.57877304803e-05,1.08509687602e-05
Prevalence,United States,Male,35 to 39,Nasopharynx cancer,Percent,2017,4.46677880713e-05,5.3140566581e-05,3.60011661258e-05
Prevalence,United States,Female,35 to 39,Nasopharynx cancer,Percent,2017,1.84879309963e-05,2.19644969502e-05,1.48413527271e-05
Prevalence,United States,Male,40 to 44,Nasopharynx cancer,Percent,2017,7.94748150793e-05,9.73836144134e-05,6.23643438664e-05
Prevalence,United States,Female,40 to 44,Nasopharynx cancer,Percent,2017,2.7916432843e-05,3.5597497458e-05,2.11857403513e-05
Prevalence,United States,Male,45 to 49,Nasopharynx cancer,Percent,2017,9.38198096689e-05,0.00010664396201,8.07046995943e-05
Prevalence,United States,Female,45 to 49,Nasopharynx cancer,Percent,2017,4.34252218357e-05,5.32101592556e-05,3.46423958799e-05
Prevalence,United States,Male,50 to 54,Nasopharynx cancer,Percent,2017,0.000108433214517,0.000122934460447,9.42443704089e-05
Prevalence,United States,Female,50 to 54,Nasopharynx cancer,Percent,2017,4.62889816362e-05,5.49514431496e-05,3.89463217171e-05
Prevalence,United States,Male,55 to 59,Nasopharynx cancer,Percent,2017,0.000105445192519,0.000120196747047,9.22329622993e-05
Prevalence,United States,Female,55 to 59,Nasopharynx cancer,Percent,2017,4.53745415668e-05,5.30741499739e-05,3.84992991225e-05
Prevalence,United States,Male,60 to 64,Nasopharynx cancer,Percent,2017,0.00010690154955,0.000123054669033,9.24879248853e-05
Prevalence,United States,Female,60 to 64,Nasopharynx cancer,Percent,2017,2.31802900055e-05,2.75872511803e-05,1.9306167949e-05
Prevalence,United States,Male,65 to 69,Nasopharynx cancer,Percent,2017,0.00012916433719,0.000145515037426,0.000113962760288
Prevalence,United States,Female,65 to 69,Nasopharynx cancer,Percent,2017,3.62100570037e-05,4.22264054523e-05,3.04786946652e-05
Prevalence,United States,Male,70 to 74,Nasopharynx cancer,Percent,2017,6.8413314861e-05,7.95525263831e-05,5.94132226444e-05
Prevalence,United States,Female,70 to 74,Nasopharynx cancer,Percent,2017,2.8007024169e-05,3.34389786863e-05,2.35446940757e-05
Prevalence,United States,Male,75 to 79,Nasopharynx cancer,Percent,2017,5.38001308314e-05,6.10764821341e-05,4.71440844781e-05
Prevalence,United States,Female,75 to 79,Nasopharynx cancer,Percent,2017,3.10860743685e-05,3.46866389115e-05,2.75818389603e-05
Prevalence,United States,Male,<1 year,Nasopharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Nasopharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Nasopharynx cancer,Percent,2017,3.26964802554e-05,3.71210646967e-05,2.96986897021e-05
Prevalence,United States,Female,80 to 84,Nasopharynx cancer,Percent,2017,2.40728053406e-05,2.77647633889e-05,2.03954956742e-05
Prevalence,United States,Male,85 to 89,Nasopharynx cancer,Percent,2017,2.99048077052e-05,3.37117609752e-05,2.69249389547e-05
Prevalence,United States,Female,85 to 89,Nasopharynx cancer,Percent,2017,2.4893668097e-05,2.88744151858e-05,2.11185499824e-05
Prevalence,United States,Male,90 to 94,Nasopharynx cancer,Percent,2017,2.35887681467e-05,2.66963535784e-05,2.14781212054e-05
Prevalence,United States,Female,90 to 94,Nasopharynx cancer,Percent,2017,1.75079373454e-05,2.0291080403e-05,1.49074023221e-05
Prevalence,United States,Male,95 plus,Nasopharynx cancer,Percent,2017,6.63517125154e-06,7.50235302029e-06,6.09280957751e-06
Prevalence,United States,Female,95 plus,Nasopharynx cancer,Percent,2017,6.87651782652e-06,7.85428496704e-06,5.91849589543e-06
Prevalence,United States,Male,1 to 4,Other pharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Other pharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Other pharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Other pharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Other pharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Other pharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Other pharynx cancer,Percent,2017,2.46918550478e-06,2.69583226909e-06,2.33882580757e-06
Prevalence,United States,Female,15 to 19,Other pharynx cancer,Percent,2017,2.0785645438e-06,2.17527205147e-06,1.97580531944e-06
Prevalence,United States,Male,20 to 24,Other pharynx cancer,Percent,2017,2.3475793429e-06,2.56440431858e-06,2.20729859446e-06
Prevalence,United States,Female,20 to 24,Other pharynx cancer,Percent,2017,2.08649806719e-06,2.20695639284e-06,1.98155734586e-06
Prevalence,United States,Male,25 to 29,Other pharynx cancer,Percent,2017,3.13659327431e-06,3.50233723235e-06,2.68791245723e-06
Prevalence,United States,Female,25 to 29,Other pharynx cancer,Percent,2017,2.8132243796e-06,3.09622258695e-06,2.47394083734e-06
Prevalence,United States,Male,30 to 34,Other pharynx cancer,Percent,2017,1.47899958872e-05,1.63530066255e-05,1.2215583405e-05
Prevalence,United States,Female,30 to 34,Other pharynx cancer,Percent,2017,5.92161661942e-06,6.60126091392e-06,5.0371750987e-06
Prevalence,United States,Male,35 to 39,Other pharynx cancer,Percent,2017,3.4707540029e-05,3.86368644545e-05,2.93137070345e-05
Prevalence,United States,Female,35 to 39,Other pharynx cancer,Percent,2017,1.29504381764e-05,1.43107686756e-05,1.1460775962e-05
Prevalence,United States,Male,40 to 44,Other pharynx cancer,Percent,2017,0.000165010805454,0.00018279247269,0.000148617545649
Prevalence,United States,Female,40 to 44,Other pharynx cancer,Percent,2017,3.37183444691e-05,3.80055411408e-05,2.96616651577e-05
Prevalence,United States,Male,45 to 49,Other pharynx cancer,Percent,2017,0.000324240782225,0.000355226849237,0.000296736726318
Prevalence,United States,Female,45 to 49,Other pharynx cancer,Percent,2017,5.07523363742e-05,5.6736865695e-05,4.57911268562e-05
Prevalence,United States,Male,50 to 54,Other pharynx cancer,Percent,2017,0.000694290945681,0.000755070270499,0.000639604979588
Prevalence,United States,Female,50 to 54,Other pharynx cancer,Percent,2017,0.000111796498277,0.000124215460055,0.000101470663398
Prevalence,United States,Male,55 to 59,Other pharynx cancer,Percent,2017,0.00095811881691,0.00104073554482,0.000882759993312
Prevalence,United States,Female,55 to 59,Other pharynx cancer,Percent,2017,0.000169632419314,0.000186281646437,0.000154048179208
Prevalence,United States,Male,60 to 64,Other pharynx cancer,Percent,2017,0.000978394106472,0.00106077231517,0.000902199140446
Prevalence,United States,Female,60 to 64,Other pharynx cancer,Percent,2017,0.000189174410535,0.000207094455544,0.000173552201517
Prevalence,United States,Male,65 to 69,Other pharynx cancer,Percent,2017,0.000862514742332,0.00093257841057,0.000790692815169
Prevalence,United States,Female,65 to 69,Other pharynx cancer,Percent,2017,0.000192025888331,0.000211913849211,0.000174616389455
Prevalence,United States,Male,70 to 74,Other pharynx cancer,Percent,2017,0.000657879518327,0.00071346959395,0.000605642657734
Prevalence,United States,Female,70 to 74,Other pharynx cancer,Percent,2017,0.000211915996874,0.000232868381496,0.000193243200293
Prevalence,United States,Male,75 to 79,Other pharynx cancer,Percent,2017,0.000315387321154,0.000339953098742,0.000290580834646
Prevalence,United States,Female,75 to 79,Other pharynx cancer,Percent,2017,0.000135950974355,0.000150994550106,0.000123472080622
Prevalence,United States,Male,<1 year,Other pharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Other pharynx cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Other pharynx cancer,Percent,2017,0.000201073845471,0.000217006720526,0.000186322495725
Prevalence,United States,Female,80 to 84,Other pharynx cancer,Percent,2017,8.81692343089e-05,9.60856557588e-05,8.05527876719e-05
Prevalence,United States,Male,85 to 89,Other pharynx cancer,Percent,2017,0.000200726127093,0.000217657618263,0.000184733968815
Prevalence,United States,Female,85 to 89,Other pharynx cancer,Percent,2017,9.83763072776e-05,0.00010729348638,9.04184744139e-05
Prevalence,United States,Male,90 to 94,Other pharynx cancer,Percent,2017,0.000190972532995,0.000206116921211,0.000176319559701
Prevalence,United States,Female,90 to 94,Other pharynx cancer,Percent,2017,9.85755177976e-05,0.000107702568413,9.0517201976e-05
Prevalence,United States,Male,95 plus,Other pharynx cancer,Percent,2017,8.32913616044e-05,9.1270356072e-05,7.63596822805e-05
Prevalence,United States,Female,95 plus,Other pharynx cancer,Percent,2017,4.67225828206e-05,5.02034165135e-05,4.31923770225e-05
Prevalence,United States,Male,1 to 4,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,15 to 19,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,20 to 24,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,20 to 24,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,25 to 29,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,25 to 29,Non-melanoma skin cancer,Percent,2017,6.12510600381e-06,1.84681136264e-05,0.0
Prevalence,United States,Male,30 to 34,Non-melanoma skin cancer,Percent,2017,9.68590588645e-05,0.00020233713021,3.77274725837e-05
Prevalence,United States,Female,30 to 34,Non-melanoma skin cancer,Percent,2017,0.000114764655005,0.000227826870081,4.64077656732e-05
Prevalence,United States,Male,35 to 39,Non-melanoma skin cancer,Percent,2017,0.000291260780881,0.000564464378416,0.000123048040204
Prevalence,United States,Female,35 to 39,Non-melanoma skin cancer,Percent,2017,0.000455227921582,0.000848473773559,0.000213857268457
Prevalence,United States,Male,40 to 44,Non-melanoma skin cancer,Percent,2017,0.000985243163718,0.00175620829963,0.000510198547054
Prevalence,United States,Female,40 to 44,Non-melanoma skin cancer,Percent,2017,0.00100453141303,0.00177992037915,0.000535080603103
Prevalence,United States,Male,45 to 49,Non-melanoma skin cancer,Percent,2017,0.00228519718507,0.00498979888773,0.000997835068036
Prevalence,United States,Female,45 to 49,Non-melanoma skin cancer,Percent,2017,0.00207025933334,0.00432233966576,0.000984512247025
Prevalence,United States,Male,50 to 54,Non-melanoma skin cancer,Percent,2017,0.00458872308504,0.00853837898563,0.00233490608616
Prevalence,United States,Female,50 to 54,Non-melanoma skin cancer,Percent,2017,0.00361984627499,0.00688763504189,0.00191842485525
Prevalence,United States,Male,55 to 59,Non-melanoma skin cancer,Percent,2017,0.00854221145993,0.0169648933551,0.00407557576227
Prevalence,United States,Female,55 to 59,Non-melanoma skin cancer,Percent,2017,0.00588679353774,0.0109797765362,0.00288668965241
Prevalence,United States,Male,60 to 64,Non-melanoma skin cancer,Percent,2017,0.0149039560201,0.0272742468839,0.00773047175447
Prevalence,United States,Female,60 to 64,Non-melanoma skin cancer,Percent,2017,0.00894396575818,0.017598317793,0.00455688900384
Prevalence,United States,Male,65 to 69,Non-melanoma skin cancer,Percent,2017,0.0250153912511,0.0409935738343,0.0134945302735
Prevalence,United States,Female,65 to 69,Non-melanoma skin cancer,Percent,2017,0.0129952382374,0.0213532259531,0.00724388752993
Prevalence,United States,Male,70 to 74,Non-melanoma skin cancer,Percent,2017,0.0351244032,0.05944300055,0.0180304992875
Prevalence,United States,Female,70 to 74,Non-melanoma skin cancer,Percent,2017,0.0170604723787,0.0287976862517,0.00878569092984
Prevalence,United States,Male,75 to 79,Non-melanoma skin cancer,Percent,2017,0.0448914619936,0.078418878025,0.0208971817344
Prevalence,United States,Female,75 to 79,Non-melanoma skin cancer,Percent,2017,0.0210652950068,0.0368219511068,0.00984335845814
Prevalence,United States,Male,<1 year,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Non-melanoma skin cancer,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Non-melanoma skin cancer,Percent,2017,0.0560931657298,0.0942454698605,0.028965349465
Prevalence,United States,Female,80 to 84,Non-melanoma skin cancer,Percent,2017,0.0256851579226,0.0440596580036,0.0125943434787
Prevalence,United States,Male,85 to 89,Non-melanoma skin cancer,Percent,2017,0.0700790956841,0.121660362079,0.0387018836048
Prevalence,United States,Female,85 to 89,Non-melanoma skin cancer,Percent,2017,0.0316050597236,0.0559892227237,0.0164926251772
Prevalence,United States,Male,90 to 94,Non-melanoma skin cancer,Percent,2017,0.0849472685628,0.165999976274,0.0398111037112
Prevalence,United States,Female,90 to 94,Non-melanoma skin cancer,Percent,2017,0.0381989331821,0.0744902560342,0.0172893811016
Prevalence,United States,Male,95 plus,Non-melanoma skin cancer,Percent,2017,0.102314699966,0.2181274128,0.0383214916039
Prevalence,United States,Female,95 plus,Non-melanoma skin cancer,Percent,2017,0.0457129794748,0.0992809298804,0.0162618711363
Prevalence,United States,Male,1 to 4,Leukemia,Percent,2017,0.000364693816182,0.000490274618899,0.000286389144235
Prevalence,United States,Female,1 to 4,Leukemia,Percent,2017,0.000426610274625,0.000617187672828,0.000303849708646
Prevalence,United States,Male,5 to 9,Leukemia,Percent,2017,0.000224010416661,0.000283191231801,0.000179376328174
Prevalence,United States,Female,5 to 9,Leukemia,Percent,2017,0.000181573063208,0.000247325326354,0.00014266642927
Prevalence,United States,Male,10 to 14,Leukemia,Percent,2017,0.00010643550243,0.000126157528511,9.09561398547e-05
Prevalence,United States,Female,10 to 14,Leukemia,Percent,2017,0.000104892199728,0.000128270477228,8.80347505149e-05
Prevalence,United States,Male,15 to 19,Leukemia,Percent,2017,9.66393765093e-05,0.000114784831212,8.37795884333e-05
Prevalence,United States,Female,15 to 19,Leukemia,Percent,2017,6.0787664522e-05,7.32736805104e-05,5.09053385967e-05
Prevalence,United States,Male,20 to 24,Leukemia,Percent,2017,0.000111716387745,0.000133532725792,9.48840116001e-05
Prevalence,United States,Female,20 to 24,Leukemia,Percent,2017,7.33809042944e-05,8.86650911488e-05,6.34808073821e-05
Prevalence,United States,Male,25 to 29,Leukemia,Percent,2017,0.000121643434596,0.000147559134312,0.000101180040997
Prevalence,United States,Female,25 to 29,Leukemia,Percent,2017,8.73090367668e-05,0.000103472921537,7.39527198785e-05
Prevalence,United States,Male,30 to 34,Leukemia,Percent,2017,0.00017700073822,0.000216706803342,0.00014457585029
Prevalence,United States,Female,30 to 34,Leukemia,Percent,2017,0.000117876637647,0.000141050133055,9.62132384225e-05
Prevalence,United States,Male,35 to 39,Leukemia,Percent,2017,0.000188367984618,0.000228487502762,0.000155712907101
Prevalence,United States,Female,35 to 39,Leukemia,Percent,2017,0.000141230758587,0.000169856538662,0.000118536415924
Prevalence,United States,Male,40 to 44,Leukemia,Percent,2017,0.000225608629473,0.000263477743755,0.000192157303802
Prevalence,United States,Female,40 to 44,Leukemia,Percent,2017,0.000180334553652,0.00021212222742,0.000152292723686
Prevalence,United States,Male,45 to 49,Leukemia,Percent,2017,0.000438925374196,0.000505061304763,0.000382998867571
Prevalence,United States,Female,45 to 49,Leukemia,Percent,2017,0.000316480941376,0.000382694449533,0.000267187978558
Prevalence,United States,Male,50 to 54,Leukemia,Percent,2017,0.000630070788376,0.000736333351215,0.000533011675124
Prevalence,United States,Female,50 to 54,Leukemia,Percent,2017,0.000486011177522,0.000588853751869,0.00040493916909
Prevalence,United States,Male,55 to 59,Leukemia,Percent,2017,0.000811390436502,0.000945090372279,0.000709548954039
Prevalence,United States,Female,55 to 59,Leukemia,Percent,2017,0.000603662589261,0.000715152040534,0.00051961779147
Prevalence,United States,Male,60 to 64,Leukemia,Percent,2017,0.0010383462536,0.00116605603936,0.000938224597937
Prevalence,United States,Female,60 to 64,Leukemia,Percent,2017,0.000724290111679,0.000854500345452,0.000637491219156
Prevalence,United States,Male,65 to 69,Leukemia,Percent,2017,0.00142072702807,0.00154588516137,0.00130681059009
Prevalence,United States,Female,65 to 69,Leukemia,Percent,2017,0.000915576120158,0.00107865620538,0.00080502152628
Prevalence,United States,Male,70 to 74,Leukemia,Percent,2017,0.00192603086443,0.00208184957271,0.00179968568903
Prevalence,United States,Female,70 to 74,Leukemia,Percent,2017,0.00115454697069,0.00128702451978,0.00105833328287
Prevalence,United States,Male,75 to 79,Leukemia,Percent,2017,0.00246319192802,0.00262668658979,0.00229328980969
Prevalence,United States,Female,75 to 79,Leukemia,Percent,2017,0.00152621746855,0.00167368429613,0.00141097731182
Prevalence,United States,Male,<1 year,Leukemia,Percent,2017,0.000429419289105,0.000607710579072,0.000301828430448
Prevalence,United States,Female,<1 year,Leukemia,Percent,2017,0.000525357906987,0.000765657770162,0.000359588102067
Prevalence,United States,Male,80 to 84,Leukemia,Percent,2017,0.00254663513283,0.00272578375498,0.00238110971929
Prevalence,United States,Female,80 to 84,Leukemia,Percent,2017,0.00161004571512,0.00174932022608,0.00149850778637
Prevalence,United States,Male,85 to 89,Leukemia,Percent,2017,0.00316778915734,0.00338518329081,0.00297004460772
Prevalence,United States,Female,85 to 89,Leukemia,Percent,2017,0.00210855131751,0.00226708368259,0.00195277829728
Prevalence,United States,Male,90 to 94,Leukemia,Percent,2017,0.00322723538254,0.00344006878481,0.0030115040913
Prevalence,United States,Female,90 to 94,Leukemia,Percent,2017,0.00227045107936,0.00243551694,0.00211327961324
Prevalence,United States,Male,95 plus,Leukemia,Percent,2017,0.000887641706132,0.00096022771486,0.000814469437218
Prevalence,United States,Female,95 plus,Leukemia,Percent,2017,0.000613548506595,0.000658548760113,0.000568232396289
Prevalence,United States,Male,1 to 4,Cardiovascular diseases,Percent,2017,0.0021455369536,0.00299114004687,0.00149374731235
Prevalence,United States,Female,1 to 4,Cardiovascular diseases,Percent,2017,0.00130875091791,0.00256685298931,0.000748054243943
Prevalence,United States,Male,5 to 9,Cardiovascular diseases,Percent,2017,0.00259998713195,0.0033181445535,0.00198088681103
Prevalence,United States,Female,5 to 9,Cardiovascular diseases,Percent,2017,0.00160130009364,0.00198997451653,0.00124178844861
Prevalence,United States,Male,10 to 14,Cardiovascular diseases,Percent,2017,0.00245983198998,0.00309188738057,0.00195512831865
Prevalence,United States,Female,10 to 14,Cardiovascular diseases,Percent,2017,0.00284344318116,0.00354959463845,0.00230424663389
Prevalence,United States,Male,15 to 19,Cardiovascular diseases,Percent,2017,0.00391471717494,0.00478484015897,0.00312710691493
Prevalence,United States,Female,15 to 19,Cardiovascular diseases,Percent,2017,0.00625222726405,0.00782078446013,0.00492455543901
Prevalence,United States,Male,20 to 24,Cardiovascular diseases,Percent,2017,0.00537844727152,0.00662612898925,0.00444976774566
Prevalence,United States,Female,20 to 24,Cardiovascular diseases,Percent,2017,0.00730945616536,0.00898591125657,0.00606070837349
Prevalence,United States,Male,25 to 29,Cardiovascular diseases,Percent,2017,0.00750577537487,0.00890027791063,0.00640108555595
Prevalence,United States,Female,25 to 29,Cardiovascular diseases,Percent,2017,0.0106252598491,0.0127094037761,0.00890728994877
Prevalence,United States,Male,30 to 34,Cardiovascular diseases,Percent,2017,0.0122620757349,0.013462760115,0.0110714160485
Prevalence,United States,Female,30 to 34,Cardiovascular diseases,Percent,2017,0.0150968470064,0.017512159513,0.013121364548
Prevalence,United States,Male,35 to 39,Cardiovascular diseases,Percent,2017,0.023079397966,0.0256740703216,0.0210333011409
Prevalence,United States,Female,35 to 39,Cardiovascular diseases,Percent,2017,0.0250081655437,0.0288410048132,0.0217041670196
Prevalence,United States,Male,40 to 44,Cardiovascular diseases,Percent,2017,0.0507133489958,0.0557137805875,0.0460878414811
Prevalence,United States,Female,40 to 44,Cardiovascular diseases,Percent,2017,0.0652237292578,0.074646853502,0.0568483297988
Prevalence,United States,Male,45 to 49,Cardiovascular diseases,Percent,2017,0.0816634386412,0.0881873273092,0.0755456607922
Prevalence,United States,Female,45 to 49,Cardiovascular diseases,Percent,2017,0.086566863095,0.0957627237714,0.0784775984542
Prevalence,United States,Male,50 to 54,Cardiovascular diseases,Percent,2017,0.130352109403,0.141974112922,0.119543829858
Prevalence,United States,Female,50 to 54,Cardiovascular diseases,Percent,2017,0.115527651187,0.127001970116,0.105620296196
Prevalence,United States,Male,55 to 59,Cardiovascular diseases,Percent,2017,0.19580764593,0.211217057968,0.18273512324
Prevalence,United States,Female,55 to 59,Cardiovascular diseases,Percent,2017,0.15521860504,0.169330269868,0.143205375487
Prevalence,United States,Male,60 to 64,Cardiovascular diseases,Percent,2017,0.276389713981,0.297200379553,0.257620808469
Prevalence,United States,Female,60 to 64,Cardiovascular diseases,Percent,2017,0.205899612693,0.222407267153,0.192160864787
Prevalence,United States,Male,65 to 69,Cardiovascular diseases,Percent,2017,0.370478162641,0.393274771519,0.348341679433
Prevalence,United States,Female,65 to 69,Cardiovascular diseases,Percent,2017,0.276649048799,0.294668393773,0.259695176159
Prevalence,United States,Male,70 to 74,Cardiovascular diseases,Percent,2017,0.46818793057,0.493767494312,0.442218889742
Prevalence,United States,Female,70 to 74,Cardiovascular diseases,Percent,2017,0.360499989073,0.382438447185,0.339232677566
Prevalence,United States,Male,75 to 79,Cardiovascular diseases,Percent,2017,0.557546957411,0.584021316294,0.530957697757
Prevalence,United States,Female,75 to 79,Cardiovascular diseases,Percent,2017,0.456198315869,0.481686936542,0.432675875669
Prevalence,United States,Male,<1 year,Cardiovascular diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Cardiovascular diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Cardiovascular diseases,Percent,2017,0.628003262548,0.655076739902,0.599773953593
Prevalence,United States,Female,80 to 84,Cardiovascular diseases,Percent,2017,0.542274492573,0.573814441861,0.513240031735
Prevalence,United States,Male,85 to 89,Cardiovascular diseases,Percent,2017,0.676180575503,0.704905642036,0.647135226835
Prevalence,United States,Female,85 to 89,Cardiovascular diseases,Percent,2017,0.619300097711,0.649764993246,0.590474572734
Prevalence,United States,Male,90 to 94,Cardiovascular diseases,Percent,2017,0.697027518039,0.726895569715,0.668942728707
Prevalence,United States,Female,90 to 94,Cardiovascular diseases,Percent,2017,0.670664785213,0.702100368798,0.638845741925
Prevalence,United States,Male,95 plus,Cardiovascular diseases,Percent,2017,0.694236663272,0.723843514299,0.663483248185
Prevalence,United States,Female,95 plus,Cardiovascular diseases,Percent,2017,0.698583495384,0.733128290591,0.665122701243
Prevalence,United States,Male,1 to 4,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,1 to 4,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,5 to 9,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,5 to 9,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Ischemic heart disease,Percent,2017,0.000146754057364,0.000177529383297,0.000118985286676
Prevalence,United States,Female,15 to 19,Ischemic heart disease,Percent,2017,0.000116808326872,0.000140880114803,9.50876189803e-05
Prevalence,United States,Male,20 to 24,Ischemic heart disease,Percent,2017,0.00041222897283,0.000472383885991,0.000357863820078
Prevalence,United States,Female,20 to 24,Ischemic heart disease,Percent,2017,0.000332299513565,0.000381898556494,0.000285960586556
Prevalence,United States,Male,25 to 29,Ischemic heart disease,Percent,2017,0.000915125763883,0.00104917894941,0.000796238661232
Prevalence,United States,Female,25 to 29,Ischemic heart disease,Percent,2017,0.000662431118041,0.000743947517928,0.000590144657289
Prevalence,United States,Male,30 to 34,Ischemic heart disease,Percent,2017,0.0021588817507,0.00247034552987,0.00188324717236
Prevalence,United States,Female,30 to 34,Ischemic heart disease,Percent,2017,0.00133551595333,0.00152081431015,0.00118762227655
Prevalence,United States,Male,35 to 39,Ischemic heart disease,Percent,2017,0.00525523887197,0.00611394500739,0.00453861293215
Prevalence,United States,Female,35 to 39,Ischemic heart disease,Percent,2017,0.00279646067737,0.00320467716289,0.00247516425428
Prevalence,United States,Male,40 to 44,Ischemic heart disease,Percent,2017,0.0112452023601,0.0130232353473,0.00970496482773
Prevalence,United States,Female,40 to 44,Ischemic heart disease,Percent,2017,0.00558028567677,0.00640822618777,0.0049203184582
Prevalence,United States,Male,45 to 49,Ischemic heart disease,Percent,2017,0.0209595899851,0.0241405765796,0.0183943482746
Prevalence,United States,Female,45 to 49,Ischemic heart disease,Percent,2017,0.0100364169621,0.0114270451873,0.00892370323247
Prevalence,United States,Male,50 to 54,Ischemic heart disease,Percent,2017,0.0358134652325,0.0425710708815,0.0308410657216
Prevalence,United States,Female,50 to 54,Ischemic heart disease,Percent,2017,0.0167371533888,0.0194447698732,0.014648205312
Prevalence,United States,Male,55 to 59,Ischemic heart disease,Percent,2017,0.0561468287411,0.0648500867395,0.0485107183868
Prevalence,United States,Female,55 to 59,Ischemic heart disease,Percent,2017,0.0256977345557,0.0294782766802,0.0223769835868
Prevalence,United States,Male,60 to 64,Ischemic heart disease,Percent,2017,0.0823645251565,0.0947929723381,0.0706892639815
Prevalence,United States,Female,60 to 64,Ischemic heart disease,Percent,2017,0.0376674542143,0.0433209220127,0.0327227160615
Prevalence,United States,Male,65 to 69,Ischemic heart disease,Percent,2017,0.123077801431,0.140285238809,0.106863593562
Prevalence,United States,Female,65 to 69,Ischemic heart disease,Percent,2017,0.0586492906214,0.0670956057851,0.0509370355154
Prevalence,United States,Male,70 to 74,Ischemic heart disease,Percent,2017,0.1600721353,0.18365581256,0.138253674583
Prevalence,United States,Female,70 to 74,Ischemic heart disease,Percent,2017,0.0812948246503,0.0941100584794,0.0694967677658
Prevalence,United States,Male,75 to 79,Ischemic heart disease,Percent,2017,0.199290997802,0.226342349099,0.172134745876
Prevalence,United States,Female,75 to 79,Ischemic heart disease,Percent,2017,0.107999772917,0.123867163227,0.0918069552677
Prevalence,United States,Male,<1 year,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,<1 year,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 to 84,Ischemic heart disease,Percent,2017,0.228380706818,0.26554264144,0.195067114881
Prevalence,United States,Female,80 to 84,Ischemic heart disease,Percent,2017,0.131013955092,0.153177206822,0.110756579575
Prevalence,United States,Male,85 to 89,Ischemic heart disease,Percent,2017,0.238253511754,0.279330129106,0.19940858505
Prevalence,United States,Female,85 to 89,Ischemic heart disease,Percent,2017,0.143319398519,0.17096955846,0.118619928938
Prevalence,United States,Male,90 to 94,Ischemic heart disease,Percent,2017,0.20082180374,0.247523927389,0.153781719915
Prevalence,United States,Female,90 to 94,Ischemic heart disease,Percent,2017,0.125000427352,0.156235864505,0.0965239591426
Prevalence,United States,Male,95 plus,Ischemic heart disease,Percent,2017,0.128457482232,0.163927294624,0.0973450794576
Prevalence,United States,Female,95 plus,Ischemic heart disease,Percent,2017,0.117777574177,0.147633955994,0.089208099819
Prevalence,United States,Male,1 to 4,Diabetes and kidney diseases,Percent,2017,0.00185831942098,0.00254294016759,0.00127971969038
Prevalence,United States,Female,1 to 4,Diabetes and kidney diseases,Percent,2017,0.00180881507166,0.0024407918428,0.00128591437349
Prevalence,United States,Male,5 to 9,Diabetes and kidney diseases,Percent,2017,0.0061901184166,0.0078211541309,0.00489012060333
Prevalence,United States,Female,5 to 9,Diabetes and kidney diseases,Percent,2017,0.00597552316582,0.00742586342814,0.00473446014373
Prevalence,United States,Male,10 to 14,Diabetes and kidney diseases,Percent,2017,0.0128008258527,0.0150519956425,0.0108153327382
Prevalence,United States,Female,10 to 14,Diabetes and kidney diseases,Percent,2017,0.0123067783234,0.0145746487457,0.0104451696936
Prevalence,United States,Male,15 to 19,Diabetes and kidney diseases,Percent,2017,0.0209599640049,0.0244200646786,0.0180956075704
Prevalence,United States,Female,15 to 19,Diabetes and kidney diseases,Percent,2017,0.0218878985719,0.0256045973946,0.0185625800133
Prevalence,United States,Male,20 to 24,Diabetes and kidney diseases,Percent,2017,0.0321319684249,0.0375365125289,0.0273576899119
Prevalence,United States,Female,20 to 24,Diabetes and kidney diseases,Percent,2017,0.0403994564084,0.0483410060503,0.0336339856145
Prevalence,United States,Male,25 to 29,Diabetes and kidney diseases,Percent,2017,0.0470949165248,0.054612224894,0.0398382949993
Prevalence,United States,Female,25 to 29,Diabetes and kidney diseases,Percent,2017,0.0677346680632,0.0813207778026,0.0553454784947
Prevalence,United States,Male,30 to 34,Diabetes and kidney diseases,Percent,2017,0.0659223093316,0.0763587560557,0.0560154719437
Prevalence,United States,Female,30 to 34,Diabetes and kidney diseases,Percent,2017,0.0978448160291,0.117299135877,0.080121258969
Prevalence,United States,Male,35 to 39,Diabetes and kidney diseases,Percent,2017,0.0956310907416,0.109838573715,0.0830409610005
Prevalence,United States,Female,35 to 39,Diabetes and kidney diseases,Percent,2017,0.124844058787,0.148716560006,0.104447287927
Prevalence,United States,Male,40 to 44,Diabetes and kidney diseases,Percent,2017,0.132883090836,0.149443974357,0.11704152953
Prevalence,United States,Female,40 to 44,Diabetes and kidney diseases,Percent,2017,0.148261934,0.170672998851,0.127192734355
Prevalence,United States,Male,45 to 49,Diabetes and kidney diseases,Percent,2017,0.174570105653,0.193658328744,0.156429943764
Prevalence,United States,Female,45 to 49,Diabetes and kidney diseases,Percent,2017,0.177525913932,0.200189063764,0.155947387097
Prevalence,United States,Male,50 to 54,Diabetes and kidney diseases,Percent,2017,0.224681781033,0.246996191164,0.205239420561
Prevalence,United States,Female,50 to 54,Diabetes and kidney diseases,Percent,2017,0.21747529988,0.241717337603,0.196390634939
Prevalence,United States,Male,55 to 59,Diabetes and kidney diseases,Percent,2017,0.289513467758,0.313424706225,0.267316602807
Prevalence,United States,Female,55 to 59,Diabetes and kidney diseases,Percent,2017,0.275687480556,0.300304316708,0.252099769728
Prevalence,United States,Male,60 to 64,Diabetes and kidney diseases,Percent,2017,0.36640768597,0.39331135471,0.340746177575
Prevalence,United States,Female,60 to 64,Diabetes and kidney diseases,Percent,2017,0.343486575967,0.372435961739,0.316932560558
Prevalence,United States,Male,65 to 69,Diabetes and kidney diseases,Percent,2017,0.441220457586,0.472282775984,0.412170480375
Prevalence,United States,Female,65 to 69,Diabetes and kidney diseases,Percent,2017,0.406892915821,0.440075013981,0.377386277048
Prevalence,United States,Male,70 to 74,Diabetes and kidney diseases,Percent,2017,0.506383332736,0.538318550357,0.476158074767
Prevalence,United States,Female,70 to 74,Diabetes and kidney diseases,Percent,2017,0.477944489233,0.511649815484,0.446818023897
Prevalence,United States,Male,75 to 79,Diabetes and kidney diseases,Percent,2017,0.563709976266,0.599075180118,0.530702113757
Prevalence,United States,Female,75 to 79,Diabetes and kidney diseases,Percent,2017,0.554870526621,0.593501989076,0.518611858769
Prevalence,United States,Male,<1 year,Diabetes and kidney diseases,Percent,2017,0.000229951317371,0.000368863098404,0.000111989102474
Prevalence,United States,Female,<1 year,Diabetes and kidney diseases,Percent,2017,0.000293799663315,0.000456941324001,0.000160848510448
Prevalence,United States,Male,80 to 84,Diabetes and kidney diseases,Percent,2017,0.61283771784,0.651783167854,0.576337985638
Prevalence,United States,Female,80 to 84,Diabetes and kidney diseases,Percent,2017,0.616005601937,0.658809126392,0.575804064779
Prevalence,United States,Male,85 to 89,Diabetes and kidney diseases,Percent,2017,0.640505815188,0.67985759521,0.60245647958
Prevalence,United States,Female,85 to 89,Diabetes and kidney diseases,Percent,2017,0.656818881174,0.700809494155,0.614494093291
Prevalence,United States,Male,90 to 94,Diabetes and kidney diseases,Percent,2017,0.658745302422,0.698042394094,0.620635781219
Prevalence,United States,Female,90 to 94,Diabetes and kidney diseases,Percent,2017,0.689698430539,0.73277285523,0.64640487164
Prevalence,United States,Male,95 plus,Diabetes and kidney diseases,Percent,2017,0.66081096857,0.698974632848,0.619288896868
Prevalence,United States,Female,95 plus,Diabetes and kidney diseases,Percent,2017,0.718947971227,0.759307243657,0.67533321622
